Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3030408	s-mta	— (—)	5160	6378	100.00%	Distribution not available
3030408	s-mta	nmol/l (nmol/l)	713	947	47.84%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Secondary hypertension

309

170

19.64

307.65

1.3

0.21

0.16

nmol/l

—

Benign neoplasm of other and unspecified endocrine glands

1132

482

29.90

307.65

1.5

1.2

0.17

0.30

nmol/l

1.02

Cardiovascular diseases (excluding rheumatic etc)

1061

1422

4.39

307.65

1.3

0.27

0.16

nmol/l

1.17

Hypertensive diseases

1484

1846

4.66

307.65

1.3

0.23

0.25

nmol/l

0.07

Benign neoplasm: Adrenal gland

1017

272

59.89

307.65

1.4

1.3

0.15

0.44

nmol/l

1.51

Antihypertensive medication - note that there are other indications

927

1060

4.87

307.65

1.3

0.26

0.36

nmol/l

0.37

Hypertension

1485

1845

4.66

307.65

1.3

0.23

0.25

nmol/l

0.07

Hypertension, essential

1519

1797

4.95

307.65

1.3

0.21

0.24

nmol/l

0.20

Hypertensive diseases (excluding secondary)

1159

1145

6.06

307.65

1.2

1.3

0.21

0.16

nmol/l

0.54

Benign neoplasm: Adrenal gland

1017

261

62.44

307.65

1.4

1.3

0.15

0.44

nmol/l

1.37

Benign neoplasm of other and unspecified endocrine glands

1132

509

28.30

307.65

1.5

1.3

0.17

0.31

nmol/l

1.07

Cardiovascular diseases

910

1168

4.31

278.65

1.3

0.30

0.17

nmol/l

1.14

Disorders of other endocrine glands

831

2210

3.80

262.70

1.7

1.2

0.34

0.21

nmol/l

0.84

131

Metabolic disorders

1381

3189

2.73

225.89

1.3

0.21

0.23

nmol/l

0.23

101

186

Abnormalities of heart beat

600

1476

4.13

214.15

1.3

0.22

0.26

nmol/l

0.25

100

Headache

972

2685

3.08

213.39

1.3

0.21

0.24

nmol/l

0.24

155

Benign neoplasms

1320

2740

2.72

208.47

1.4

1.2

0.22

0.26

nmol/l

0.33

153

General symptoms and signs

1517

2988

2.58

208.08

1.3

0.24

nmol/l

0.01

173

Malaise and fatigue

764

1843

3.53

207.79

1.3

0.25

nmol/l

0.00

125

Pain in throat and chest

1174

2588

2.81

201.86

1.3

0.21

0.24

nmol/l

0.48

158

Other heart diseases

656

1120

3.93

193.69

1.3

0.22

0.16

nmol/l

0.80

Exclusions for E4_PCOS_BROAD

396

771

5.36

192.67

2.2

1.2

0.36

0.31

nmol/l

0.16

Abnormalities of breathing

1191

2664

2.69

187.54

1.3

0.18

0.24

nmol/l

0.89

159

Benign neoplasms

1054

2084

2.90

186.93

1.4

1.2

0.23

0.21

nmol/l

0.15

Other disorders of fluid, electrolyte and acid-base balance

510

1214

4.17

182.30

1.2

1.3

0.30

0.27

nmol/l

0.09

Endocrine, nutritional and metabolic diseases

1061

1912

2.86

177.16

1.3

1.2

0.22

0.25

nmol/l

0.23

Symptoms and signs involving the circulatory and respiratory systems

1323

2677

2.51

172.24

1.3

0.19

0.24

nmol/l

0.62

160

Cardiac arrhythmias

872

1993

2.94

165.77

1.3

1.2

0.23

0.28

nmol/l

0.31

Hypokalaemia

270

442

6.41

158.39

1.2

1.3

0.41

0.32

nmol/l

0.14

Anaemias

295

297

6.72

154.46

1.3

1.2

0.29

0.13

nmol/l

1.25

Medical observation and evaluation for suspected diseases and conditions

936

1750

2.77

148.81

1.3

0.19

0.25

nmol/l

0.59

113

Other disorders of adrenal gland

156

150

11.36

143.84

3.3

1.2

0.48

0.35

nmol/l

0.22

Disorders of lipoprotein metabolism and other lipidaemias

1048

2739

2.44

137.83

1.3

0.21

0.23

nmol/l

0.28

175

Other heart diseases, wide

1213

3362

2.26

135.24

1.3

0.22

0.26

nmol/l

0.42

199

Neoplasms

912

1876

2.63

134.08

1.5

1.1

0.27

0.17

nmol/l

0.93

Malignant neoplasm of adrenal gland

101.71

131.21

5.0

1.3

0.62

—

nmol/l

—

Other arrhythmias

882

2718

2.52

130.88

1.3

0.25

0.26

nmol/l

0.09

175

Hypothyroidism (congenital or acquired)

308

320

5.61

127.97

1.4

1.2

0.16

0.13

nmol/l

0.37

Any gastric operation

982

2004

2.48

126.08

1.3

1.2

0.27

0.26

nmol/l

0.08

111

GASTRO-related operations

982

2004

2.48

126.08

1.3

1.2

0.27

0.26

nmol/l

0.08

111

Dyspnoea

1124

3952

2.20

123.68

1.3

0.29

0.22

nmol/l

0.39

255

Hypertensive heart and/or renal disease

322

550

4.63

123.51

1.3

1.2

0.21

0.36

nmol/l

0.63

Episodal and paroxysmal disorders

1351

3289

2.12

123.05

1.3

0.21

0.23

nmol/l

0.23

207

Diseases of arteries, arterioles and capillaries (FINNGEN)

336

528

4.54

121.06

1.3

0.20

0.18

nmol/l

0.11

Hypothyroidism and >3 levothyroxin purchases

297

317

5.46

120.49

1.5

1.2

0.16

0.13

nmol/l

—

Hypothyroidism, levothyroxine purchases

297

317

5.46

120.49

1.5

1.2

0.16

0.13

nmol/l

—

Abnormal blood-pressure reading, without diagnosis

137

144

10.21

118.23

1.2

1.4

0.27

0.45

nmol/l

—

Diseases of oesophagus, stomach and duodenum

1320

3925

2.06

116.69

1.3

0.24

nmol/l

0.03

244

Cerebrovascular diseases (FINNGEN)

392

739

3.86

116.39

1.4

1.2

0.26

0.18

nmol/l

0.64

Other diseases of intestines

1285

3635

2.07

114.00

1.3

0.20

0.25

nmol/l

0.63

225

Adrenomedullary hyperfunction

115.25

111.37

6.3

1.2

0.58

—

nmol/l

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

216

402

5.68

111.22

3.2

1.2

0.41

0.39

nmol/l

0.04

Hypertensive Heart Disease

274

494

4.62

107.16

1.3

1.2

0.25

0.41

nmol/l

0.50

Dizziness and giddiness

942

3490

2.22

106.63

1.3

0.21

0.25

nmol/l

0.45

241

Sleep disorders (combined)

1217

3957

2.04

105.83

1.3

0.26

0.23

nmol/l

0.11

266

Other soft tissue disorders, not elsewhere classified

1113

3280

2.12

105.71

1.2

1.3

0.26

0.23

nmol/l

0.15

191

Symptoms and signs involving cognition, perception, emotional state and behaviour

1167

4050

2.04

103.56

1.3

0.19

0.25

nmol/l

1.06

264

Abdominal and pelvic pain

1171

2847

2.09

101.49

1.2

1.3

0.23

0.21

nmol/l

0.24

203

Pain in joint

694

1834

2.53

100.88

1.3

0.18

0.22

nmol/l

0.44

123

Symptoms and signs involving the digestive system and abdomen

1169

2847

2.07

99.94

1.3

0.24

0.21

nmol/l

0.34

203

Pure hypercholesterolaemia

845

2507

2.29

98.74

1.3

0.22

0.24

nmol/l

0.10

170

Sleep apnoea, including avohilmo

1174

3826

2.01

98.57

1.3

0.28

0.23

nmol/l

0.24

265

Atrial fibrillation and flutter

372

683

3.61

97.76

1.3

1.2

0.25

0.18

nmol/l

0.52

Other headache syndromes

559

2163

2.62

95.83

1.3

0.23

0.24

nmol/l

0.07

130

Paroxysmal tachycardia

281

593

4.08

95.01

1.3

1.2

0.31

0.18

nmol/l

0.77

Examination and observation for other reasons

700

1740

2.47

94.60

1.3

0.19

0.25

nmol/l

0.58

113

Type 2 diabetes, wide definition

964

2981

2.13

94.31

1.3

0.18

0.25

nmol/l

1.40

181

Sleep apnoea

1107

3770

2.01

94.01

1.3

0.25

0.23

nmol/l

0.09

266

Depression medications

300

341

4.47

93.28

1.2

1.3

0.25

0.13

nmol/l

0.61

Tramadol

942

2877

2.13

91.47

1.3

0.20

0.22

nmol/l

0.34

164

Codeine

1118

3085

2.01

90.04

1.3

0.31

0.22

nmol/l

0.55

166

Pain in limb

907

3158

2.10

87.50

1.2

1.3

0.30

0.23

nmol/l

0.32

184

Persons encountering health services in other circumstances, wide

1384

3925

1.84

85.69

1.3

0.21

0.24

nmol/l

0.39

247

Nausea and vomiting

350

1098

3.19

85.60

1.3

0.45

0.24

nmol/l

0.44

Heart failure and antihypertensive medication

273

448

4.09

85.25

1.3

0.17

0.43

nmol/l

0.83

Dorsalgia

1149

3228

1.94

84.17

1.3

0.22

0.25

nmol/l

0.22

198

Symptoms and signs involving the nervous and musculoskeletal systems

700

3182

2.23

83.55

1.3

0.24

0.26

nmol/l

0.12

206

Neurological diseases

1002

2483

2.05

83.14

1.2

1.3

0.22

0.18

nmol/l

0.41

141

Codeine or tramadol medication

1321

4002

1.84

82.99

1.3

0.29

0.21

nmol/l

0.57

244

Cushing syndrome

19.26

82.36

1.3

1.1

0.35

—

nmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

406

642

3.20

81.80

1.3

0.43

0.17

nmol/l

1.10

Opioids

1140

3119

1.93

81.76

1.3

0.19

0.22

nmol/l

0.38

166

Other functional intestinal disorders

533

2073

2.48

80.79

1.3

0.30

0.27

nmol/l

0.13

150

Hypothyroidism, drug reimbursement

164

199

5.98

80.38

1.6

1.2

0.16

0.12

nmol/l

—

Parasetamol

906

2228

2.09

79.79

1.2

1.3

0.21

0.22

nmol/l

0.03

129

Atrial fibrillation and flutter with reimbursement

298

534

3.63

78.67

1.3

0.24

0.19

nmol/l

0.32

Other CVD (FINNGEN)

150

204

5.93

75.58

1.4

1.2

0.53

0.16

nmol/l

1.21

Neurological diseases, wide definition

352

536

3.33

75.25

1.2

1.3

0.24

0.13

nmol/l

0.60

Diabetes, varying definitions

1160

3780

1.85

75.01

1.3

0.17

0.25

nmol/l

2.17

209

Low back pain

825

3148

2.04

74.80

1.3

0.28

0.25

nmol/l

0.18

194

Other nutritional deficiencies

761

3643

2.06

74.61

1.2

1.3

0.14

0.26

nmol/l

2.61

224

Diabetes mellitus

1162

3792

1.84

74.48

1.3

0.17

0.25

nmol/l

2.17

209

Syncope and collapse

491

1768

2.49

74.09

1.3

0.36

0.26

nmol/l

0.61

127

Benzodiazepine use

1128

4410

1.84

74.04

1.3

0.16

0.26

nmol/l

2.42

260

Migraine

573

2118

2.33

73.86

1.2

1.3

0.23

0.21

nmol/l

0.11

109

Type 2 diabetes

1118

3596

1.86

73.76

1.3

0.16

0.25

nmol/l

2.48

204

General examination and investigation of persons without complaint and reported diagnosis

719

1749

2.21

73.12

1.3

0.19

0.25

nmol/l

0.71

113

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1228

3915

1.80

72.46

1.3

0.23

0.24

nmol/l

0.09

247

Pain, not elsewhere classified

340

1179

2.93

72.23

1.3

0.27

0.17

nmol/l

0.68

Gastro-oesophageal reflux disease

775

3413

2.03

71.65

1.3

0.27

0.24

nmol/l

0.16

230

Spondylopathies

900

2786

1.98

71.57

1.3

0.23

0.25

nmol/l

0.14

185

Diverticular disease of intestine

789

2570

2.06

71.30

1.3

0.17

0.25

nmol/l

1.27

197

Type 2 diabetes, definitions combined, including avohilmo

1073

3442

1.86

70.70

1.3

0.17

0.25

nmol/l

2.19

199

Malignant neoplasm of endocrine gland

161

345

4.89

70.58

3.2

1.2

0.50

0.42

nmol/l

0.12

Type 2 diabetes, definitions combined

1062

3442

1.86

69.63

1.3

0.17

0.25

nmol/l

2.11

202

Type 2 diabetes, strict (exclude DM1)

1067

3470

1.85

69.32

1.3

0.17

0.25

nmol/l

1.80

204

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1075

4268

1.82

68.87

1.3

0.24

0.23

nmol/l

0.01

249

Lower back pain or/and sciatica

1138

4441

1.79

68.79

1.3

0.24

nmol/l

0.03

281

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

449

1838

2.49

68.75

1.5

1.3

0.22

0.21

nmol/l

0.03

128

Disorders of thyroid, IBD co-morbidities

216

397

4.02

68.70

1.2

0.11

0.14

nmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

952

3701

1.89

68.28

1.3

0.28

0.22

nmol/l

0.57

226

Fever of other and unknown origin

554

2295

2.26

68.01

1.3

0.14

0.25

nmol/l

1.64

145

Anxiety disorders, excluding more controls

950

3384

1.88

66.04

1.3

0.18

0.27

nmol/l

1.28

189

Mood disorders, excluding more controls

1059

3571

1.82

65.45

1.3

0.14

0.27

nmol/l

3.25

206

Other symptoms and signs involving the nervous and musculoskeletal systems

513

2275

2.29

65.32

1.3

0.22

0.24

nmol/l

0.09

152

Obesity

711

3555

2.00

64.35

1.2

1.3

0.13

0.26

nmol/l

3.14

222

Obesity and other hyperalimentation

713

3566

2.00

64.33

1.2

1.3

0.13

0.26

nmol/l

3.13

223

Implicit Sepsis

812

3295

1.93

63.73

1.3

0.28

0.23

nmol/l

0.30

219

Gastrointestinal diseases

655

1522

2.17

63.25

1.2

1.3

0.24

0.30

nmol/l

0.24

Hyperlipidaemia, other/unspecified

420

1635

2.46

62.83

1.3

0.19

0.26

nmol/l

0.89

121

Other antidepressants

1126

3323

1.78

62.70

1.3

0.18

0.28

nmol/l

1.61

191

Benign neoplasm: Carotid body

55.79

62.67

4.6

1.3

0.18

—

nmol/l

—

Pain (limb, back, neck, head abdominally)

764

1897

2.03

62.33

1.2

1.3

0.22

nmol/l

0.04

130

Irritable bowel syndrome

358

1380

2.64

62.19

1.2

1.3

0.12

0.23

nmol/l

2.30

Obesity due to excess calories

552

2585

2.16

61.46

1.2

1.3

0.13

0.24

nmol/l

2.98

157

Other dorsopathies, not elsewhere classified

1088

3237

1.79

61.36

1.3

0.22

0.25

nmol/l

0.20

198

Benign neoplasm: Carotid body

51.09

61.16

4.6

1.3

0.18

—

nmol/l

—

First line medication for Crohn's disease

1208

3849

1.72

60.87

1.3

0.16

0.26

nmol/l

2.15

235

Functional dyspepsia

350

1352

2.63

60.61

1.3

1.2

0.14

0.20

nmol/l

1.60

Depression or dysthymia

791

2271

1.97

60.58

1.3

0.13

0.31

nmol/l

2.85

140

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1040

3586

1.78

60.55

1.3

0.18

0.25

nmol/l

1.39

207

Anxiety disorders

1009

4070

1.77

59.05

1.3

0.17

0.23

nmol/l

0.96

244

Neurotic, stress-related and somatoform disorders

999

4037

1.77

58.75

1.3

0.17

0.24

nmol/l

1.00

240

Other specific joint derangements/joint disorders

811

2888

1.90

58.62

1.3

0.19

0.25

nmol/l

0.99

170

Asthma, excluding more controls

840

2366

1.91

58.33

1.2

1.3

0.31

0.25

nmol/l

0.21

128

Used for control exclusion in common control thyroid runs

1115

3260

1.74

57.73

1.3

0.19

0.24

nmol/l

0.51

206

Symptoms and signs concerning food and fluid intake

150

356

4.32

57.41

1.2

1.3

0.15

0.19

nmol/l

—

Mood [affective] disorders

1122

4350

1.71

57.14

1.3

0.14

0.27

nmol/l

4.02

248

Mood disorders

1123

4356

1.71

56.78

1.3

0.14

0.27

nmol/l

4.04

250

Other special examinations and investigations of persons without complaint or reported diagnosis

696

1750

2.03

56.66

1.2

1.3

0.20

0.25

nmol/l

0.51

113

Dorsopathies

1101

3250

1.74

56.57

1.3

0.24

0.25

nmol/l

0.09

198

Asthma, unspecified (mode), excluding more controls

572

2161

2.10

56.56

1.3

0.35

0.24

nmol/l

0.28

124

Heart failure, not strict

824

3076

1.86

56.56

1.3

0.24

nmol/l

0.02

201

Disorders of parathyroid gland

278

977

2.87

56.43

1.3

1.2

0.49

0.26

nmol/l

0.42

Diabetes medication

1105

3940

1.72

56.30

1.3

0.18

0.24

nmol/l

1.25

231

Depression

1053

4236

1.72

55.90

1.3

0.14

0.27

nmol/l

3.91

235

Asthma

860

2501

1.86

55.37

1.2

1.3

0.31

0.24

nmol/l

0.24

141

Diabetes, insulin treatment (Kela reimbursement)

1078

3880

1.71

54.45

1.3

0.18

0.24

nmol/l

1.23

233

Spondylosis

579

2452

2.05

54.44

1.2

1.3

0.27

0.25

nmol/l

0.08

175

Other (not insulin) diabetes medications

1034

3623

1.73

54.42

1.3

0.18

0.24

nmol/l

1.44

223

Other intervertebral disc disorders

883

3002

1.81

54.40

1.3

0.21

0.25

nmol/l

0.37

192

Hyperparathyroidism

249

842

2.99

54.38

1.3

1.2

0.42

0.26

nmol/l

0.25

Complications of surgical and medical care, not elsewhere classified

1031

4360

1.71

53.39

1.3

0.16

0.26

nmol/l

2.66

269

ILD medications: prednisolone, methylprednisolone, prednisone

1172

3990

1.67

53.27

1.3

0.17

0.26

nmol/l

1.92

247

Persons encountering health services in other circumstances

435

1967

2.24

52.84

1.2

1.3

0.14

0.21

nmol/l

1.34

123

Biguanides

1011

3638

1.73

52.62

1.3

0.17

0.24

nmol/l

1.74

226

Asthma (only as main-diagnosis), excluding more controls

745

2366

1.89

51.88

1.3

0.33

0.25

nmol/l

0.25

128

Oral corticosteroids

1128

4124

1.67

51.52

1.3

0.17

0.26

nmol/l

1.79

260

Adrenocortical insufficiency

126

6.88

51.50

1.7

1.2

0.16

0.41

nmol/l

—

Chronic kidney disease

306

1193

2.59

51.45

1.4

1.3

0.19

0.31

nmol/l

0.92

Disorders of gallbladder, biliary tract and pancreas

1034

3950

1.70

51.44

1.3

0.19

0.26

nmol/l

0.93

257

Asthma, unspecified (mode)

576

2284

2.02

51.44

1.3

0.34

0.24

nmol/l

0.29

136

Exclusions for E4_PCOS_CONSORTIUM

815

2829

1.82

51.07

1.5

1.2

0.38

0.20

nmol/l

0.96

148

Sciatica+with lumbago

549

2606

2.02

50.83

1.2

1.3

0.22

0.26

nmol/l

0.31

160

STROKE

632

2261

1.96

50.43

1.3

0.25

0.28

nmol/l

0.21

141

Persons encountering health services for specific procedures and health care

1132

4275

1.65

50.20

1.3

0.21

0.22

nmol/l

0.15

245

Any mental disorder

1186

3622

1.65

50.05

1.3

0.18

0.27

nmol/l

1.54

211

Asthma (mode)

829

2532

1.81

49.62

1.2

1.3

0.32

0.24

nmol/l

0.28

144

Anxiety (asthma-related co-morbidities)

653

2723

1.91

49.58

1.3

0.17

0.23

nmol/l

0.66

134

Inflammatory bowel disease treatment related agents

1198

4210

1.63

49.25

1.3

0.17

0.26

nmol/l

1.92

260

Renal tubulo-interstitial diseases

893

3993

1.73

48.83

1.3

0.22

0.24

nmol/l

0.09

238

Oedema, not elsewhere classified

319

1305

2.46

48.35

1.3

0.27

0.28

nmol/l

0.04

Any reimbursement code in KELA

614

1551

2.00

48.05

1.3

0.27

0.20

nmol/l

0.38

Recurrent or chronic depression

456

1538

2.16

47.98

1.2

1.3

0.13

0.26

nmol/l

2.17

Asthma (only as main-diagnosis)

754

2501

1.83

47.91

1.3

0.34

0.24

nmol/l

0.36

141

Hypopituitarism

105

219

4.94

47.40

1.4

1.2

0.14

0.32

nmol/l

—

Psychiatric diseases

1159

3572

1.63

47.27

1.3

0.19

0.27

nmol/l

1.05

206

ILD medications

1181

4032

1.62

47.17

1.3

0.16

0.26

nmol/l

2.49

248

Statin medication

749

2315

1.83

46.46

1.2

1.3

0.18

0.27

nmol/l

1.25

131

Intracranial trauma

549

2085

1.98

46.31

1.2

1.3

0.25

0.17

nmol/l

0.37

116

Hypo-osmolality and hyponatraemia

200

661

3.07

46.30

1.2

1.3

0.20

0.28

nmol/l

0.55

Concussion

476

2022

2.05

45.59

1.2

1.3

0.25

0.17

nmol/l

0.31

115

All anxiety disorders

657

2888

1.85

45.38

1.3

0.17

0.22

nmol/l

0.54

164

Migraine without aura

238

877

2.76

45.37

1.3

1.2

0.16

0.31

nmol/l

—

Soft tissue disorders

1050

3323

1.65

44.95

1.2

1.3

0.18

0.23

nmol/l

0.68

192

Renal failure

424

1841

2.13

44.89

1.3

0.25

0.27

nmol/l

0.09

133

Constipation

889

3788

1.69

44.68

1.3

0.24

nmol/l

0.04

242

Other/unspecified dorsalgia

402

1878

2.15

44.56

1.3

0.43

0.25

nmol/l

0.84

113

Dysphagia

259

1005

2.61

44.55

1.3

0.21

0.26

nmol/l

0.40

Complications of procedures, not elsewhere classified

827

4211

1.71

44.53

1.3

0.15

0.26

nmol/l

2.47

263

Fibromyalgia

142

391

3.73

44.48

1.3

1.2

0.12

0.51

nmol/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

654

3356

1.82

44.31

1.3

0.24

nmol/l

0.01

245

Hypertensive Renal Disease

9.29

43.56

1.4

1.2

0.13

0.46

nmol/l

—

Disorders of the thyroid gland

959

3813

1.65

43.49

1.3

0.31

0.23

nmol/l

0.36

256

Somatoform disorder

223

819

2.78

42.94

1.3

0.15

0.31

nmol/l

1.59

Disorders of mineral metabolism

122

310

4.05

42.88

1.2

1.3

0.22

0.44

nmol/l

—

Symptoms and signs involving the skin and subcutaneous tissue

712

4079

1.75

42.72

1.3

0.18

0.25

nmol/l

0.93

258

Chronic lower respiratory diseases

1232

4285

1.56

42.72

1.3

0.24

0.23

nmol/l

0.03

261

Postprocedural endocrine and metabolic disorders, not elsewhere classified

165

518

3.26

42.07

1.8

1.2

0.42

0.40

nmol/l

0.04

Benign neoplasm of colon, rectum, anus and anal canal

558

2108

1.91

41.72

1.4

1.2

0.19

0.24

nmol/l

0.53

153

Disturbances of skin sensation

326

1454

2.27

41.28

1.3

0.25

0.24

nmol/l

0.03

Persons encountering health services for examination and investigation

644

1750

1.86

40.94

1.3

0.20

0.25

nmol/l

0.38

113

Nerve, nerve root and plexus disorders

1072

4270

1.59

40.82

1.2

1.3

0.16

0.26

nmol/l

2.05

273

Disorder of lipoprotein metabolism, unspecified

159

497

3.26

40.80

1.4

1.3

0.53

0.28

nmol/l

0.35

Asthma (diagnoses ohter than nonallergic)

866

4531

1.64

40.37

1.2

1.3

0.30

0.23

nmol/l

0.28

290

Continuous positive airway pressure

192

569

2.95

40.29

1.2

1.3

0.11

0.24

nmol/l

—

Other metabolic disorders

171

565

3.09

39.99

1.8

1.2

0.40

0.38

nmol/l

0.03

Excluding asthma or asthma-COPD overlap

848

2521

1.70

39.82

1.2

1.3

0.23

0.24

nmol/l

0.05

141

Other pulmonary diagnosis

845

2521

1.69

39.18

1.2

1.3

0.23

0.24

nmol/l

0.03

141

Spinal stenosis

500

2059

1.92

38.87

1.2

1.3

0.27

0.26

nmol/l

0.07

165

Ischaemic heart disease, wide definition

789

2940

1.69

38.66

1.3

0.20

0.26

nmol/l

0.64

210

Vocal cord dysfunction

149

425

3.30

38.56

1.4

1.2

0.27

0.14

nmol/l

0.44

Hernia of abdominal wall, postoperative

178

616

2.93

38.24

1.4

1.2

0.14

0.30

nmol/l

0.65

Cholelithiasis

840

3596

1.65

38.23

1.3

0.20

0.26

nmol/l

0.59

242

Follow-up examination after treatment for conditions other than malignant neoplasms

437

1430

2.02

37.76

1.3

0.15

0.27

nmol/l

1.52

Lumbar disc prolapse

636

2890

1.76

37.73

1.3

0.23

0.26

nmol/l

0.12

187

Cholelithiasis, broad definition with cholecystitis

865

3654

1.63

37.72

1.3

0.20

0.26

nmol/l

0.61

244

Ischemic heart diseases

793

2982

1.68

37.66

1.3

0.21

0.26

nmol/l

0.51

208

Abnormal weight loss

131

385

3.50

37.30

1.2

1.3

0.14

0.34

nmol/l

—

Hypothyroidism, other/unspecified

878

3597

1.62

36.98

1.3

0.33

0.23

nmol/l

0.39

239

COPD differential diagnosis

837

2532

1.67

36.89

1.2

1.3

0.24

nmol/l

0.00

144

ILD differential diagnosis

837

2532

1.67

36.88

1.2

1.3

0.24

nmol/l

0.00

144

Migraine with aura

257

1091

2.38

36.52

1.2

1.3

0.15

0.26

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

354

1048

2.16

36.21

1.2

0.28

0.17

nmol/l

0.80

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

141

444

3.24

35.84

1.5

1.3

0.20

0.45

nmol/l

1.06

Symptoms and signs involving the urinary system

752

3528

1.66

35.70

1.3

0.29

0.23

nmol/l

0.38

243

Abnormal findings on examination of blood, without diagnosis

438

2149

1.92

35.47

1.3

0.17

0.28

nmol/l

1.48

158

Hard cardiovascular diseases

790

3095

1.65

35.44

1.4

1.3

0.24

nmol/l

0.01

213

Weight loss

136

424

3.29

35.24

1.2

1.3

0.14

0.37

nmol/l

—

Disorders of calcium metabolism

229

4.23

35.08

1.2

1.3

0.16

0.50

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

131

400

3.35

35.05

1.6

1.3

0.20

0.47

nmol/l

1.07

Obesity related asthma

370

1849

2.03

34.96

1.2

1.3

0.47

0.25

nmol/l

0.37

137

Other anxiety disorders

461

2187

1.88

34.77

1.3

0.20

0.25

nmol/l

0.40

115

Selective serotonin reuptake inhibitors

988

3336

1.57

34.58

1.3

0.17

0.28

nmol/l

1.88

191

Infections, IBD-co-morbidities

149

343

3.20

34.42

1.3

1.2

0.28

0.14

nmol/l

0.40

Haemorrhage from respiratory passages

296

1261

2.20

34.41

1.3

0.19

0.27

nmol/l

0.82

100

Cough

367

1759

2.02

34.35

1.2

1.3

0.19

0.25

nmol/l

0.56

117

Rheumatism, unspecified

192

735

2.66

34.23

1.2

1.3

0.17

0.29

nmol/l

0.69

Diarrhoea and gastroenteritis of presumed infectious origin

686

3763

1.67

34.15

1.3

0.22

0.27

nmol/l

0.36

220

Autoimmune diseases excluding thyroid diseases, strict definition

968

3467

1.56

33.99

1.3

0.19

0.23

nmol/l

0.92

219

Hypothyreosis and Thyroxine purchase for inclusion criteria

907

3826

1.57

33.84

1.3

0.33

0.23

nmol/l

0.40

254

Autoimmune diseases excluding thyroid diseases

1011

3658

1.54

33.35

1.3

0.21

0.23

nmol/l

0.20

233

Autoimmune diseases

1092

3683

1.52

33.32

1.3

0.28

0.23

nmol/l

0.24

233

Cholecystectomy

695

3744

1.65

33.29

1.3

0.15

0.26

nmol/l

2.21

256

Certain infectious and parasitic diseases

1011

3292

1.55

32.99

1.3

0.20

0.27

nmol/l

0.85

185

Benign neoplasm of other and ill-defined parts of digestive system

204

829

2.50

32.13

1.4

1.2

0.29

0.27

nmol/l

0.04

Cervical disc disorders

370

1905

1.96

32.09

1.3

0.29

0.28

nmol/l

0.04

137

Other disorders of urethra and urinary system

676

3072

1.66

32.08

1.2

1.3

0.20

0.23

nmol/l

0.26

193

Shoulder lesions

747

2820

1.63

31.94

1.2

1.3

0.20

0.23

nmol/l

0.22

180

Benign neoplasm: Colon

467

1963

1.84

31.79

1.4

1.2

0.21

0.24

nmol/l

0.35

148

Non-invasive ventilation

194

721

2.55

31.76

1.5

1.3

0.19

0.23

nmol/l

0.22

Cystitis

827

3209

1.58

31.37

1.3

0.23

nmol/l

0.05

201

Myalgia

249

1116

2.26

31.30

1.2

1.3

0.19

0.25

nmol/l

0.50

Diaphragmatic hernia

376

1969

1.93

31.07

1.2

1.3

0.25

nmol/l

0.03

147

Genitourinary diseases

578

1658

1.76

31.05

1.3

0.20

0.26

nmol/l

0.45

105

Asthma-related infections

554

3214

1.71

30.61

1.3

0.16

0.23

nmol/l

1.52

200

Asthma, hospital admission 2, infections

554

3214

1.71

30.61

1.3

0.16

0.23

nmol/l

1.52

200

Diseases of the skin and subcutaneous tissue

1013

3362

1.52

30.56

1.3

0.22

0.25

nmol/l

0.24

212

COPD/asthma related infections

1063

3562

1.50

30.44

1.3

0.23

0.26

nmol/l

0.15

206

COPD/asthma/ILD related infections

1063

3562

1.50

30.44

1.3

0.23

0.26

nmol/l

0.15

206

Cervicalgia

225

980

2.33

30.31

1.3

0.19

0.21

nmol/l

0.07

Visual disturbances and blindness

496

2850

1.76

30.25

1.3

0.28

0.25

nmol/l

0.15

195

437

2400

1.82

30.20

1.3

0.16

0.23

nmol/l

1.25

147

Asthma, including avohilmo

1129

4483

1.47

30.08

1.2

1.3

0.29

0.22

nmol/l

0.29

292

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

920

4124

1.52

30.04

1.4

1.3

0.19

0.25

nmol/l

0.97

259

1118

4015

1.48

29.94

1.3

0.18

0.26

nmol/l

1.33

246

Abnormal findings on diagnostic imaging of other body structures

166

633

2.68

29.93

1.4

1.3

0.17

0.30

nmol/l

—

Other joint disorders

859

2942

1.56

29.93

1.3

0.15

0.25

nmol/l

2.30

174

Complications of medical and surgical care

700

4179

1.60

29.87

1.3

0.16

0.25

nmol/l

1.85

276

Other disorders of kidney and ureter

156

578

2.75

29.75

1.5

1.3

0.21

0.31

nmol/l

0.54

Bleeding

780

3636

1.57

29.41

1.3

0.24

nmol/l

0.01

252

Benign neoplasm of colon, rectum, anus and anal canal

577

3129

1.68

29.39

1.4

1.3

0.19

0.25

nmol/l

0.83

247

Hypotension

165

633

2.65

29.29

1.4

1.3

0.53

0.26

nmol/l

0.75

Other CVD

190

780

2.47

29.25

1.4

1.3

0.53

0.25

nmol/l

0.82

Finngen Rheumatological endpoints

947

3582

1.51

29.08

1.3

0.20

0.23

nmol/l

0.27

218

Pain in thoracic spine

171

674

2.58

28.75

1.2

1.3

0.23

0.25

nmol/l

—

Viral Sepsis

195

818

2.42

28.65

1.3

0.15

0.24

nmol/l

1.07

Aplastic and other anaemias

399

2067

1.85

28.62

1.3

0.25

0.27

nmol/l

0.16

152

Implicit viral Sepsis

194

816

2.41

28.34

1.3

0.15

0.24

nmol/l

1.07

Visual disturbances

464

2667

1.75

28.33

1.3

0.30

0.25

nmol/l

0.22

184

Insulin medication

539

2752

1.69

27.87

1.3

0.32

0.24

nmol/l

0.25

182

Other neurological diseases

675

3423

1.60

27.79

1.3

0.21

0.25

nmol/l

0.38

244

Temporomandibular joint disorders

163

638

2.59

27.76

1.3

0.15

0.22

nmol/l

—

Asthma, hospital admissions , main diagnosis only

780

4571

1.54

27.70

1.3

0.34

0.22

nmol/l

0.44

287

Intestinal infectious diseases

879

4587

1.50

27.22

1.3

0.20

0.25

nmol/l

0.66

278

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

863

3373

1.52

27.21

1.6

1.2

0.20

0.24

nmol/l

0.62

195

Benign neoplasm of other and ill-defined parts of digestive system

204

895

2.32

27.16

1.4

1.3

0.29

0.27

nmol/l

0.03

Use of hypnotics and sedatives

1022

4043

1.47

27.14

1.3

0.16

0.27

nmol/l

2.74

240

Other symptoms and signs involving the digestive system and abdomen

174

711

2.48

27.12

1.3

0.17

0.26

nmol/l

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

862

3373

1.52

27.03

1.6

1.2

0.20

0.24

nmol/l

0.62

195

Malignant neoplasm, wide definition for exclusion

862

3375

1.52

26.96

1.6

1.2

0.20

0.24

nmol/l

0.62

195

Diseases of the musculoskeletal system and connective tissue

512

1480

1.74

26.95

1.2

1.3

0.25

0.27

nmol/l

0.08

Disorders of eyelid, lacrimal system and orbit

792

4093

1.53

26.75

1.2

1.3

0.19

0.24

nmol/l

0.82

290

Paralytic ileus and intestinal obstruction

234

1092

2.16

26.64

1.3

0.12

0.32

nmol/l

1.89

Diseases of the digestive system

413

2335

1.78

26.49

1.3

0.31

0.26

nmol/l

0.20

170

Dental pulpitis 4, only avohilmo

1056

3799

1.46

26.46

1.2

1.3

0.26

0.24

nmol/l

0.16

258

Personality disorders, excluding more controls

251

1208

2.10

26.40

1.2

1.3

0.15

0.28

nmol/l

1.70

Other and unspecified anaemias

361

1901

1.85

26.35

1.3

0.26

0.29

nmol/l

0.15

139

Dental pulpitis 1, only avohilmo

1058

3814

1.45

26.26

1.2

1.3

0.26

0.24

nmol/l

0.14

258

Nutritional anaemias

440

2474

1.74

26.24

1.3

0.27

0.25

nmol/l

0.09

170

Migraine without aura and triptan purchases

181

765

2.40

26.22

1.2

1.3

0.11

0.35

nmol/l

—

Ovarian cyst

390

1221

1.86

26.20

1.2

1.3

0.14

0.20

nmol/l

0.88

Other anaemias

364

1924

1.84

26.03

1.3

0.26

0.28

nmol/l

0.12

143

Diseases of the ear and mastoid process

1140

4042

1.43

25.99

1.3

0.21

0.24

nmol/l

0.28

253

Valvular heart disease excluding rheumatic fever

424

1752

1.78

25.96

1.4

1.3

0.22

0.28

nmol/l

0.36

134

Glucagon-like peptide-1 (GLP-1) analogues

498

2441

1.69

25.89

1.3

0.19

0.25

nmol/l

0.95

182

Hypothyroidism, strict autoimmune

671

2824

1.58

25.82

1.3

0.35

0.24

nmol/l

0.30

190

Obesity, other/unspecified

339

1826

1.87

25.78

1.2

1.3

0.15

0.23

nmol/l

1.37

109

Dental pulpitis 1

1030

3688

1.46

25.78

1.2

1.3

0.25

0.23

nmol/l

0.13

245

Subjective visual disturbances

259

1274

2.06

25.77

1.3

0.25

0.26

nmol/l

—

Care involving use of rehabilitation procedures

604

3611

1.60

25.73

1.3

0.16

0.22

nmol/l

1.20

224

Clear cell adenocarcinoma of kidney

169

4.23

25.72

1.4

1.3

0.19

0.39

nmol/l

—

Diseases of arteries, arterioles and capillaries

600

2790

1.62

25.70

1.3

0.18

0.26

nmol/l

1.12

211

Dental pulpitis 4

1029

3687

1.46

25.64

1.2

1.3

0.25

0.23

nmol/l

0.13

245

Non-rheumatic valve diseases

421

1742

1.78

25.58

1.4

1.3

0.22

0.28

nmol/l

0.38

134

Other and unspecified iron deficiency

308

1612

1.93

25.57

1.3

0.24

0.23

nmol/l

0.06

101

Malignant neoplasm of kidney, except renal pelvis

106

346

3.13

25.53

1.6

1.3

0.20

0.32

nmol/l

0.57

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

170

4.20

25.52

1.4

1.2

0.19

0.43

nmol/l

—

Autoimmune diseases related-to ILD

801

4721

1.50

25.42

1.3

0.16

0.25

nmol/l

2.29

296

Insulin, intermediate and long-acting

499

2960

1.66

25.19

1.3

0.30

0.24

nmol/l

0.20

214

Acute upper respiratory infections

986

4274

1.45

25.13

1.3

0.19

0.25

nmol/l

0.92

271

Malignant neoplasm of urinary organs

110

371

3.02

25.03

1.6

1.3

0.20

0.31

nmol/l

0.53

Exposure to unspecified factor

898

4774

1.47

25.00

1.3

0.29

0.23

nmol/l

0.42

298

Disorders of vestibular function (Vertigo)

452

2655

1.71

24.95

1.3

0.17

0.25

nmol/l

1.08

192

Other bacterial diseases

874

4108

1.48

24.86

1.3

0.19

0.25

nmol/l

1.17

256

Diseases of inner ear

512

3063

1.65

24.85

1.3

0.23

0.24

nmol/l

0.04

216

Other systemic involvement of connective tissue (FG)

271

1364

2.00

24.78

1.3

0.14

0.24

nmol/l

1.85

Other and unspecified effects of external causes

277

1416

1.98

24.72

1.2

1.3

0.28

0.24

nmol/l

0.17

Urticaria and erythema

368

2061

1.80

24.67

1.2

1.3

0.29

0.23

nmol/l

0.39

121

Diseases of pulp and periapical tissues, including avohilmo

1022

3686

1.45

24.64

1.2

1.3

0.25

0.23

nmol/l

0.13

245

Dermatitis and eczema

1014

4650

1.44

24.60

1.3

0.29

0.22

nmol/l

0.42

303

Endometriosis

369

1195

1.85

24.57

1.3

0.37

0.20

nmol/l

0.48

Polyuria

210

972

2.19

24.53

1.3

0.35

0.32

nmol/l

0.07

Non-selective monoamine reuptake inhibitors

384

2114

1.78

24.48

1.3

0.15

0.28

nmol/l

2.50

122

Other diseases of upper respiratory tract

1048

3821

1.44

24.36

1.2

1.3

0.21

0.25

nmol/l

0.26

236

Adverse effects, not elsewhere classified

212

989

2.17

24.30

1.2

1.3

0.22

0.30

nmol/l

—

Abnormal involuntary movements

148

592

2.54

24.25

1.3

0.38

0.32

nmol/l

—

Other diseases of urinary system

949

3681

1.46

24.17

1.3

0.25

0.23

nmol/l

0.17

235

Other noninfective gastroenteritis and colitis

243

1199

2.05

23.93

1.3

0.21

0.26

nmol/l

0.38

Systemic connective tissue disorders

349

1952

1.80

23.56

1.3

0.14

0.24

nmol/l

2.43

128

Rotator cuff syndrome

558

2595

1.61

23.47

1.2

1.3

0.20

0.23

nmol/l

0.17

171

Benign neoplasm: Colon

472

2815

1.65

23.28

1.4

1.3

0.21

0.25

nmol/l

0.42

230

Nonorganic sleeping disorders, excluding more controls

181

807

2.27

23.20

1.3

0.24

0.28

nmol/l

—

Urticaria

301

1623

1.87

22.90

1.2

1.3

0.33

0.25

nmol/l

0.37

Other gastritis (incl. Duodenitis)

218

1052

2.10

22.89

1.2

1.3

0.14

0.21

nmol/l

1.57

149

616

2.45

22.76

1.5

1.3

0.19

0.32

nmol/l

0.69

Oxycodone

313

1652

1.85

22.76

1.3

0.21

0.23

nmol/l

0.17

119

Infections of the skin and subcutaneous tissue

522

3265

1.60

22.72

1.3

0.19

0.26

nmol/l

0.79

201

Diseases of the eye and adnexa

789

2647

1.50

22.68

1.2

1.3

0.31

0.21

nmol/l

0.54

190

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

480

2898

1.63

22.51

1.3

0.20

0.25

nmol/l

0.31

188

Factors influencing health status and contact with health services

273

682

2.02

22.48

1.3

0.22

0.24

nmol/l

0.05

Other reaction to severe stress, and adjustment disorders

347

1970

1.78

22.26

1.3

1.2

0.14

0.25

nmol/l

1.92

102

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

242

1228

1.99

22.15

1.3

0.58

0.30

nmol/l

0.25

Noninfective enteritis and colitis

435

2627

1.67

22.15

1.3

0.19

0.23

nmol/l

0.51

167

Iron deficiency anaemia

373

2144

1.74

22.10

1.3

0.22

0.27

nmol/l

0.32

137

Enthesopathies of lower limb, excluding foot

218

1067

2.06

22.05

1.2

1.3

0.12

0.20

nmol/l

1.65

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

328

3.02

22.04

1.2

—

0.18

nmol/l

—

Substance abuse, excluding more controls

473

2546

1.63

22.01

1.2

1.3

0.15

0.29

nmol/l

2.48

158

Gingivitis and periodontal diseases

850

3009

1.46

21.94

1.3

0.22

0.24

nmol/l

0.18

204

Adjustment and management of implanted device

168

744

2.29

21.93

1.3

0.20

0.31

nmol/l

0.55

Convulsions, not elsewhere classified

195

904

2.15

21.92

1.3

0.18

nmol/l

0.05

Cerebrovascular diseases

665

3152

1.52

21.86

1.4

1.3

0.20

0.25

nmol/l

0.60

235

Fall on same level

1082

4349

1.40

21.79

1.3

0.20

0.24

nmol/l

0.62

260

Insulin, combination of fast acting with intermediate-acting or long-acting

539

3175

1.57

21.59

1.3

0.32

0.23

nmol/l

0.30

224

Coronary atherosclerosis

618

2592

1.55

21.57

1.3

0.19

0.26

nmol/l

0.80

191

Diseases of the respiratory system

636

2061

1.55

21.53

1.2

1.3

0.28

0.26

nmol/l

0.12

120

Other and unspecified urticaria

208

1011

2.08

21.49

1.2

1.3

0.35

0.28

nmol/l

0.26

Chronic gastritis

256

1339

1.93

21.42

1.2

1.3

0.22

0.28

nmol/l

0.27

Major coronary heart disease event excluding revascularizations

589

2628

1.56

21.42

1.4

1.3

0.24

0.26

nmol/l

0.15

210

Disorders of conjunctiva

753

4322

1.47

21.28

1.3

0.26

0.24

nmol/l

0.14

271

Falls/tendency to fall

1061

3811

1.40

21.28

1.3

0.21

0.24

nmol/l

0.23

233

Diseases of oral cavity, salivary glands and jaws

851

3013

1.45

21.23

1.3

0.25

0.24

nmol/l

0.05

204

Acute upper respiratory infections of multiple and unspecified sites

675

3389

1.50

21.02

1.2

1.3

0.17

0.23

nmol/l

0.56

210

Polyarthropathies

603

2619

1.54

20.97

1.2

1.3

0.21

0.26

nmol/l

0.42

165

Implicit bacterial Sepsis

328

1715

1.77

20.48

1.3

0.17

0.27

nmol/l

1.01

127

Other systemic involvement of connective tissue

275

1495

1.86

20.48

1.3

1.2

0.14

0.26

nmol/l

2.05

Cluster headache, wide

140

4.11

20.33

1.5

0.10

0.51

nmol/l

—

Osteopathies and chondropathies

507

3082

1.57

20.19

1.3

0.24

0.22

nmol/l

0.19

198

Hernia

867

4155

1.42

20.17

1.3

0.27

0.23

nmol/l

0.28

264

Other or unspecified ileus, impaction or obstruction

162

732

2.24

20.15

1.3

0.12

0.25

nmol/l

1.72

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

546

3552

1.54

20.12

1.3

0.16

0.26

nmol/l

1.77

245

Dentinal caries

212

1057

2.01

20.11

1.3

0.17

0.22

nmol/l

0.47

Enlarged lymph nodes

147

640

2.32

20.01

1.3

0.36

0.18

nmol/l

0.47

Other enthesopathies

285

1578

1.82

19.98

1.2

1.3

0.20

0.26

nmol/l

0.28

100

Care involving dialysis

309

2.97

19.95

1.4

1.3

0.25

0.35

nmol/l

0.38

Cervicobrachial syndrome

216

1094

1.99

19.92

1.2

1.3

0.27

0.21

nmol/l

0.18

Any event in cancer register

862

3605

1.42

19.80

1.6

1.2

0.20

0.24

nmol/l

0.51

207

Dialysis, with operation codes

130

541

2.44

19.66

1.3

0.23

0.32

nmol/l

0.43

External causes of morbidity and mortality

656

2185

1.51

19.65

1.3

0.26

0.24

nmol/l

0.10

126

Arthropathies

830

2945

1.44

19.64

1.3

0.17

0.25

nmol/l

1.58

174

Migraine with aura and triptan purchases

159

722

2.23

19.61

1.2

1.3

0.16

0.38

nmol/l

—

Chronic pancreatitis

130

542

2.44

19.60

1.5

1.3

0.18

0.29

nmol/l

0.83

Asthma/COPD (KELA code 203)

853

4269

1.41

19.42

1.2

1.3

0.30

0.23

nmol/l

0.25

259

Benign paroxysmal vertigo

276

1531

1.82

19.29

1.3

0.18

0.24

nmol/l

0.73

112

809

3559

1.43

19.25

1.3

0.25

0.26

nmol/l

0.05

206

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

809

3559

1.43

19.25

1.3

0.25

0.26

nmol/l

0.05

206

COPD (mode)

276

1204

1.83

19.08

1.3

0.17

0.24

nmol/l

1.11

Glomerular disorders in diseases classified elsewhere

119

483

2.50

19.03

1.2

1.3

0.18

0.29

nmol/l

0.62

Disorders of synovium and tendon

470

2701

1.58

18.97

1.2

1.3

0.23

nmol/l

0.00

163

Extracorporeal dialysis

214

3.35

18.92

1.4

1.3

0.28

0.37

nmol/l

0.26

Panic disorder

149

669

2.25

18.90

1.4

1.3

0.13

0.36

nmol/l

1.36

Other and unspecified dermatitis

464

2969

1.57

18.81

1.3

0.41

0.24

nmol/l

0.64

197

Major coronary heart disease event

629

2829

1.49

18.76

1.4

1.3

0.23

0.25

nmol/l

0.19

219

Intestinal stricture

272

1520

1.81

18.55

1.3

0.14

0.28

nmol/l

2.52

110

GI-bleeding

261

1440

1.83

18.53

1.3

0.37

0.29

nmol/l

0.26

108

Glomerular diseases

173

833

2.10

18.42

1.2

1.3

0.17

0.25

nmol/l

0.62

Heart failure,strict

446

2027

1.60

18.38

1.3

0.16

0.24

nmol/l

1.54

146

Behavioural syndromes associated with physiological disturbances and physical factors

290

1656

1.76

18.31

1.3

0.21

0.22

nmol/l

0.06

Other diseases of the digestive system

263

1462

1.81

18.24

1.3

0.36

0.29

nmol/l

0.23

108

Dental caries

233

1235

1.88

18.23

1.4

1.3

0.16

0.27

nmol/l

1.05

Acute sinusitis

474

2857

1.56

18.17

1.3

0.18

0.21

nmol/l

0.40

167

Polycystic ovarian syndrome, consortium definition

681

2823

1.46

18.12

1.3

0.26

0.21

nmol/l

0.30

148

Conjunctivitis

678

4104

1.45

18.10

1.3

0.26

0.21

nmol/l

0.47

249

Dermatitis

542

3618

1.51

18.08

1.3

0.40

0.24

nmol/l

0.74

242

Myocardial infarction, without ST-elevation

311

1674

1.73

18.01

1.3

0.17

0.30

nmol/l

1.41

136

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

373

2.68

17.97

2.0

1.2

0.12

0.39

nmol/l

—

Coxibs

240

665

1.93

17.91

1.3

0.20

0.25

nmol/l

—

Bronchitis

957

4598

1.37

17.91

1.2

1.3

0.16

0.25

nmol/l

1.68

288

Abnormal findings on diagnostic imaging of lung

397

2413

1.61

17.86

1.3

0.24

0.26

nmol/l

0.07

195

Dentofacial anomalies [including malocclusion]

260

1436

1.81

17.76

1.4

1.2

0.13

0.22

nmol/l

1.53

Angina pectoris

531

2363

1.53

17.75

1.3

0.22

0.26

nmol/l

0.36

181

Myocardial infarction

437

1986

1.59

17.65

1.4

1.3

0.20

0.29

nmol/l

0.85

152

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

504

3331

1.52

17.62

1.3

0.16

0.26

nmol/l

1.50

224

Cluster headache, wide,, including avohilmo

219

3.23

17.59

1.4

1.3

0.12

0.48

nmol/l

—

Gonarthrosis [arthrosis of knee](FG)

688

2811

1.45

17.29

1.2

1.3

0.28

0.23

nmol/l

0.17

200

Nephropathy related operations

123

530

2.36

17.28

1.3

0.25

0.29

nmol/l

0.22

Pacemaker

253

1374

1.80

17.20

1.3

0.24

0.32

nmol/l

0.34

110

COPD

371

1885

1.63

17.18

1.3

0.19

0.26

nmol/l

0.82

147

Collagenous colitis

102

406

2.56

17.08

1.3

0.23

0.41

nmol/l

0.68

Gonarthrosis

585

2260

1.49

17.07

1.2

1.3

0.31

0.26

nmol/l

0.14

161

Other congenital malformations

365

2.64

17.04

2.3

1.3

0.18

0.45

nmol/l

—

Other diseases of intestine

114

478

2.42

17.01

1.4

1.3

0.10

0.31

nmol/l

—

Other external causes of accidental injury

796

2836

1.41

16.92

1.3

0.19

0.24

nmol/l

0.38

172

Malignant neoplasm

816

3483

1.40

16.81

1.6

1.2

0.20

0.23

nmol/l

0.47

206

Generalized anxiety disorder

146

683

2.16

16.79

1.3

1.2

0.12

0.38

nmol/l

1.56

Tinnitus

228

1248

1.85

16.74

1.4

1.3

0.17

0.22

nmol/l

—

Injuries to the ankle and foot

606

3820

1.45

16.66

1.2

1.3

0.24

0.22

nmol/l

0.12

225

Soft tissue disorders related to use, overuse and pressure

241

1343

1.81

16.66

1.2

1.3

0.23

0.27

nmol/l

0.19

Cluster headache, strict, including avohilmo

201

3.26

16.63

1.4

1.3

0.12

0.45

nmol/l

—

Persons with potential health hazards related to communicable diseases

329

1982

1.66

16.60

1.3

0.21

nmol/l

0.03

Covid-19 confirmed case

248

1397

1.79

16.52

1.2

1.3

0.40

0.24

nmol/l

0.34

Disorders resulting from impaired renal tubular function

130

3.88

16.48

1.4

0.20

0.37

nmol/l

—

Acute renal failure

169

842

2.03

16.44

1.3

0.29

0.28

nmol/l

0.01

Bacterial Sepsis

358

1974

1.62

16.40

1.3

0.17

0.26

nmol/l

1.01

143

Accidents

792

2836

1.40

16.38

1.3

0.19

0.24

nmol/l

0.44

172

Sleep disorders

206

1100

1.89

16.36

1.2

1.3

0.22

0.25

nmol/l

—

Other disorders of lacrimal gland

315

1902

1.67

16.35

1.2

1.3

0.15

0.23

nmol/l

—

143

Other chronic obstructive pulmonary disease, including avohilmo

440

2382

1.55

16.18

1.2

1.3

0.18

0.27

nmol/l

1.40

180

Disorders of lacrimal system

376

2380

1.59

16.10

1.2

1.3

0.15

0.22

nmol/l

1.06

173

Other diseases of pancreas

313

2.74

16.09

1.3

0.13

0.39

nmol/l

—

Inflammatory diseases of female pelvic organs

573

2963

1.47

16.07

1.2

1.3

0.20

0.22

nmol/l

0.22

159

Parodontitis or operation codes

802

4299

1.38

16.05

1.3

0.19

0.24

nmol/l

0.67

285

Injuries to the knee and lower leg

1056

4562

1.33

15.94

1.2

1.3

0.18

0.25

nmol/l

1.30

275

Undetermined asthma, excluding more controls

122

542

2.28

15.93

1.2

0.16

0.27

nmol/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

735

3594

1.40

15.89

1.3

0.35

0.23

nmol/l

0.35

232

Diseases of pulp and periapical tissues

307

1855

1.67

15.88

1.2

1.3

0.32

0.27

nmol/l

0.18

129

Influenza and pneumonia

937

4589

1.35

15.85

1.3

0.24

nmol/l

0.02

268

Other disorders of teeth and supporting structures

195

1035

1.90

15.79

1.3

0.22

0.26

nmol/l

0.13

Disorders of skin appendages

422

2752

1.54

15.78

1.2

1.3

0.15

0.22

nmol/l

1.03

164

Carbimazole or st.post thyroidectomy, condition for graves disease

205

1108

1.87

15.72

1.6

1.3

0.27

0.28

nmol/l

0.01

Nonorganic sleeping disorders

181

940

1.95

15.67

1.3

0.24

0.28

nmol/l

—

Acetic acid derivatives and related substances

234

658

1.86

15.67

1.2

1.3

0.19

0.25

nmol/l

0.32

Noninfectious colitis NAS

132

611

2.19

15.65

1.3

0.22

0.35

nmol/l

—

Cutaneous abscess, furuncle and carbuncle

233

1311

1.79

15.63

1.3

0.17

0.23

nmol/l

0.68

Urolithiasis

267

1562

1.72

15.61

1.2

1.3

0.13

0.30

nmol/l

1.99

115

Migraine, single triptan purchase ok & required. ICD-code if available is included

718

3482

1.40

15.60

1.3

0.21

nmol/l

0.06

201

Triptan medication for migraine, single purchase ok

718

3482

1.40

15.60

1.3

0.21

nmol/l

0.06

201

Chronic rhinitis, nasopharyngitis and pharyngitis

290

1735

1.68

15.60

1.2

1.3

0.13

0.24

nmol/l

2.41

107

Parodontitis

798

4303

1.37

15.49

1.3

0.19

0.24

nmol/l

0.67

285

Cerebral cysts

215

3.08

15.49

1.4

1.3

0.12

0.43

nmol/l

—

Chronic periodontitis, including avohilmo

795

4306

1.37

15.38

1.3

0.19

0.24

nmol/l

0.67

285

Benign neoplasm of brain and other parts of central nervous system

270

2.83

15.37

2.1

1.2

0.13

0.40

nmol/l

—

Gastroduodenal ulcer

203

1100

1.85

15.27

1.3

0.34

0.28

nmol/l

0.11

Disorders of vitreous body

429

2772

1.52

15.20

1.2

1.3

0.19

0.25

nmol/l

0.58

214

Epilepsy

241

1380

1.75

15.05

1.3

0.20

0.27

nmol/l

0.57

101

Thyrotoxicosis, other and/or unspecified

190

1017

1.89

15.03

1.2

1.3

0.16

0.26

nmol/l

—

Benign neoplasm of brain and other parts of central nervous system

274

2.79

14.96

2.1

1.3

0.13

0.45

nmol/l

—

Other symptoms and signs involving cognitive functions and awareness

345

2040

1.60

14.91

1.3

0.19

0.27

nmol/l

0.86

158

Excessive, frequent and irregular menstruation

360

1247

1.62

14.90

1.3

0.20

nmol/l

0.01

Sequelae of external causes of morbidity and mortality

224

1265

1.79

14.89

1.2

1.3

0.15

0.24

nmol/l

1.71

Personality disorders

251

1464

1.73

14.87

1.2

0.15

0.24

nmol/l

1.55

Carpal tunnel syndrome

540

3376

1.45

14.86

1.2

1.3

0.14

0.26

nmol/l

3.03

223

Hyperkalaemia

149

3.48

14.85

1.3

1.4

0.13

0.46

nmol/l

—

Undetermined asthma

122

559

2.21

14.82

1.2

1.3

0.16

0.25

nmol/l

—

Disorders of vitreous body and globe

437

2840

1.51

14.81

1.2

1.3

0.18

0.25

nmol/l

0.70

221

Explicit Sepsis

336

2023

1.60

14.80

1.4

1.2

0.18

0.26

nmol/l

0.77

133

Substance use, excluding alcohol

187

1002

1.88

14.75

1.3

0.16

0.28

nmol/l

1.21

Acute tubulo-interstitial nephritis

509

3094

1.47

14.75

1.3

0.26

0.25

nmol/l

0.06

196

Aortic aneurysm

164

828

1.96

14.61

1.2

1.3

0.11

0.36

nmol/l

—

Heart failure, strict

471

2279

1.50

14.59

1.3

0.16

0.28

nmol/l

2.06

177

Other diseases of hard tissues of teeth

560

2906

1.44

14.58

1.3

0.19

0.24

nmol/l

0.52

193

Other chronic obstructive pulmonary disease

346

1823

1.59

14.38

1.3

0.17

0.26

nmol/l

1.42

143

Transient ischemic attack

432

2384

1.51

14.36

1.3

0.25

nmol/l

0.00

188

Provisional assignment of new diseases of uncertain etiology

373

2423

1.55

14.29

1.2

1.3

0.38

0.22

nmol/l

0.36

148

Codes for special purposes

374

2431

1.55

14.28

1.2

1.3

0.38

0.22

nmol/l

0.37

149

Persons encountering health services for specific procedures, not carried out

304

2.64

14.23

1.4

1.3

0.34

0.41

nmol/l

0.21

Calculus of kidney and ureter

248

1460

1.71

14.23

1.2

1.3

0.14

0.26

nmol/l

1.81

104

Early onset COPD, excluding more controls

175

931

1.89

14.09

1.2

1.3

0.15

0.25

nmol/l

1.54

Intracranial injury

473

3124

1.47

14.09

1.2

1.3

0.25

0.23

nmol/l

0.07

200

Sequelae with surgical and medical care as external cause

181

975

1.88

14.09

1.3

0.15

0.26

nmol/l

1.58

Cardiomyopathy

146

731

2.02

14.08

1.3

0.25

0.39

nmol/l

0.49

Thyrotoxicosis

240

1406

1.72

14.06

1.2

1.3

0.14

0.27

nmol/l

1.95

Unstable angina pectoris

303

1552

1.63

14.00

1.3

0.27

0.30

nmol/l

0.13

130

Brachial plexus disorders

416

2.36

13.88

1.2

1.3

0.14

0.38

nmol/l

—

Other disorders of bladder

110

498

2.24

13.85

1.2

1.3

0.30

0.26

nmol/l

—

Arthrosis

630

2463

1.41

13.81

1.3

0.16

0.26

nmol/l

1.95

165

Gonarthrosis,primary

764

3544

1.36

13.79

1.2

1.3

0.28

0.23

nmol/l

0.15

265

Phobic anxiety disorders

120

563

2.15

13.78

1.2

1.3

0.19

0.34

nmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

507

3379

1.44

13.76

1.5

1.3

0.18

0.23

nmol/l

0.61

184

Other diseases of anus and rectum

231

1345

1.73

13.75

1.3

0.22

0.30

nmol/l

0.46

105

Injuries to the head

948

4708

1.32

13.72

1.3

0.33

0.21

nmol/l

0.95

282

Injury, poisoning and certain other consequences of external causes

504

1719

1.48

13.69

1.2

1.3

0.34

0.26

nmol/l

0.28

Mental and behavioural disorders due to psychoactive substance use

488

3183

1.45

13.69

1.2

1.3

0.15

0.27

nmol/l

2.44

199

Polyarthrosis

191

1011

1.83

13.66

1.2

1.3

0.13

0.29

nmol/l

2.64

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

422

2479

1.50

13.62

1.2

1.3

0.24

0.22

nmol/l

0.07

127

Other symptoms and signs involving the urinary system

389

2.40

13.59

1.4

1.3

0.38

0.32

nmol/l

—

Conduction disorders

222

1060

1.75

13.52

1.3

0.17

0.33

nmol/l

0.98

Adhesive capsulitis of shoulder

156

812

1.94

13.50

1.3

0.15

0.27

nmol/l

—

Unspecified haematuria

321

1742

1.59

13.47

1.3

0.18

0.26

nmol/l

0.86

136

Parodontitis and operation codes

745

4294

1.35

13.47

1.3

0.19

0.25

nmol/l

0.78

286

Pain associated with micturition

114

530

2.18

13.46

1.2

1.3

0.19

0.34

nmol/l

—

Insulin, fast-acting

298

1867

1.61

13.38

1.3

0.17

0.26

nmol/l

1.16

121

All-cause Heart Failure

457

2241

1.48

13.38

1.3

0.16

0.28

nmol/l

2.12

176

Diseases of salivary glands

178

971

1.85

13.33

1.3

0.16

0.23

nmol/l

0.88

Malignant neoplasm of thyroid gland

327

2.52

13.29

1.9

1.3

0.12

0.43

nmol/l

—

Later onset COPD, excluding more controls

166

681

1.92

13.29

1.3

0.18

0.27

nmol/l

0.88

Allergic asthma (mode), excluding more controls

200

1109

1.78

13.26

1.2

1.3

0.21

0.25

nmol/l

—

Substance abuse

473

3135

1.45

13.09

1.2

1.3

0.15

0.27

nmol/l

2.46

196

Haemorrhoids and perianal venous thrombosis

230

1359

1.70

13.02

1.3

0.33

0.30

nmol/l

0.07

104

Other arthrosis

443

2156

1.48

12.99

1.3

0.23

0.26

nmol/l

0.19

158

COPD related to multimorbidity

295

1558

1.60

12.90

1.3

0.17

0.30

nmol/l

1.30

129

Ocular pain

362

2.41

12.88

1.3

0.12

0.38

nmol/l

—

Mouth breathing

348

2280

1.53

12.86

1.2

1.3

0.12

0.25

nmol/l

4.26

166

Other septicaemia

284

1745

1.61

12.81

1.4

1.3

0.18

0.31

nmol/l

1.24

127

Chronic sinusitis

370

2459

1.51

12.79

1.2

1.3

0.16

0.23

nmol/l

1.43

154

Fenamates

138

461

2.03

12.73

1.4

1.3

0.18

0.26

nmol/l

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

322

2.49

12.69

1.4

1.3

0.22

0.28

nmol/l

—

Other disorders of skin and subcutaneous tissue

567

3738

1.40

12.69

1.3

0.17

0.25

nmol/l

1.61

260

Cardiodefibrillation

282

1766

1.60

12.68

1.3

0.26

0.27

nmol/l

0.05

150

Benign neoplasm: Rectum, anus and anal canal

167

908

1.86

12.67

1.5

1.2

0.15

0.34

nmol/l

1.72

Other extrapyramidal and movement disorders in other diseases

196

1120

1.77

12.61

1.3

0.42

0.19

nmol/l

0.56

Temporomandibular joint disorders, including avohilmo

363

2412

1.51

12.52

1.3

1.2

0.13

0.24

nmol/l

2.71

120

Benign neoplasm: Transverse colon

404

2.31

12.52

1.4

1.3

0.30

0.35

nmol/l

—

Gout

199

1038

1.76

12.52

1.2

1.3

0.25

0.28

nmol/l

0.15

Other disorders of ear

792

3980

1.33

12.50

1.3

0.27

0.23

nmol/l

0.20

271

Diseases of liver

288

1823

1.59

12.48

1.3

0.16

0.25

nmol/l

1.43

127

Allergic asthma (mode)

200

1133

1.74

12.36

1.2

1.3

0.21

0.25

nmol/l

—

Cyst of kidney

268

2.62

12.28

1.3

0.25

0.38

nmol/l

—

Other and unspecified polyneuropathies, also in other diseases

158

853

1.87

12.28

1.3

0.20

0.25

nmol/l

—

Radiculopathy

139

720

1.95

12.24

1.4

1.3

0.41

0.23

nmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

867

4606

1.31

12.23

1.3

0.24

nmol/l

0.05

274

Other disorders of eye and adnexa

130

659

1.99

12.21

1.2

1.3

0.12

0.34

nmol/l

—

All pneumoniae

871

4615

1.31

12.18

1.3

0.24

nmol/l

0.06

275

Transport accidents

381

2279

1.49

12.08

1.2

1.3

0.15

0.26

nmol/l

1.63

135

Other retinal disorders

510

2913

1.41

12.06

1.3

0.17

0.26

nmol/l

1.66

225

Insulin, fast-acting or short human

300

1931

1.56

12.05

1.3

0.17

0.25

nmol/l

1.13

122

Disorders of adult personality and behaviour

250

1543

1.63

12.05

1.2

0.14

0.24

nmol/l

1.60

Abnormalities of gait and mobility

102

475

2.17

12.04

1.3

0.16

0.34

nmol/l

—

Artrosis, including avohilmo

732

2997

1.34

12.02

1.3

0.19

0.23

nmol/l

0.43

207

Specific personality disorders

208

1226

1.71

11.98

1.2

0.14

0.26

nmol/l

1.58

Irregular menses

416

2320

1.46

11.86

1.2

0.25

0.21

nmol/l

0.14

117

AV-block

128

589

1.99

11.81

1.3

0.15

0.48

nmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

302

1553

1.56

11.79

1.3

0.21

0.30

nmol/l

0.87

124

Cardiomyopathy, other and unspecified

316

2.44

11.73

1.3

0.39

0.33

nmol/l

—

Other inflammation of eyelid

122

615

2.01

11.68

1.3

0.18

0.32

nmol/l

—

Mental and behavioural disorders due to tobacco

379

2.30

11.65

1.2

1.3

0.18

0.39

nmol/l

1.12

Acute bronchitis

325

2104

1.52

11.60

1.2

1.3

0.14

0.26

nmol/l

2.73

142

Osteoporosis

221

1272

1.67

11.60

1.4

1.3

0.27

0.25

nmol/l

0.06

Septicaemia

310

1950

1.54

11.56

1.4

1.3

0.18

0.30

nmol/l

1.16

141

Polyneuropathies and other disorders of the peripheral nervous system

174

986

1.78

11.56

1.3

0.19

0.24

nmol/l

0.51

Other and unspecified disorders of vitreous body

355

2381

1.49

11.55

1.2

1.3

0.16

0.26

nmol/l

1.44

188

Non-ischemic cardiomyopathy

230

1145

1.66

11.54

1.3

0.16

0.38

nmol/l

1.59

Injuries to the neck

193

1127

1.73

11.53

1.2

1.3

0.13

0.26

nmol/l

1.79

Other noninflammatory disorders of uterus, except cervix

211

847

1.71

11.51

1.3

1.2

0.34

0.22

nmol/l

0.42

Smoking dependency

382

2.28

11.44

1.2

1.3

0.18

0.39

nmol/l

1.12

Meniscus derangement

474

2289

1.42

11.43

1.3

0.16

0.26

nmol/l

2.13

161

COPD, hospital admissions

344

1946

1.50

11.39

1.3

0.17

0.29

nmol/l

1.53

152

Certain disorders involving the immune mechanism

175

999

1.77

11.36

1.2

1.3

0.24

0.26

nmol/l

—

Pneumonia, organism unspecified

771

4258

1.31

11.35

1.3

0.25

0.24

nmol/l

0.11

256

Gastric ulcer

138

732

1.90

11.35

1.2

1.3

0.45

0.26

nmol/l

0.29

Other diseases of liver

163

912

1.80

11.34

1.4

1.3

0.17

0.29

nmol/l

1.14

Erysipelas

439

2818

1.43

11.26

1.2

1.3

0.14

0.26

nmol/l

2.85

208

COPD, early/later onset

346

1960

1.50

11.24

1.3

0.17

0.29

nmol/l

1.56

155

Benign neoplasm: Rectum

147

799

1.86

11.24

1.4

1.2

0.15

0.32

nmol/l

1.34

Volume depletion

268

2.53

11.21

1.6

1.3

0.19

0.37

nmol/l

—

Benign neoplasm: Stomach

450

2.16

11.20

1.3

0.37

0.34

nmol/l

0.07

Nonalcoholic fatty liver disease

444

2.17

11.17

1.3

0.20

0.36

nmol/l

—

Benign neoplasm: Caecum

418

2.21

11.17

1.3

0.13

0.33

nmol/l

—

Insomnia

143

772

1.87

11.17

1.2

1.3

0.23

0.30

nmol/l

—

Myocardial infarction, strict

373

1852

1.48

11.07

1.4

1.3

0.19

0.29

nmol/l

1.05

144

Extrapyramidal and movement disorders

295

1933

1.54

11.03

1.4

1.3

0.56

0.21

nmol/l

2.88

132

Deforming dorsopathies

226

1392

1.63

11.03

1.3

0.25

0.21

nmol/l

0.19

Unspecified kidney failure

325

2.37

11.02

1.4

1.3

0.18

0.34

nmol/l

0.74

ILD medications: immunosuppressive drugs

515

3589

1.38

11.02

1.3

0.24

0.26

nmol/l

0.17

223

Benign neoplasm: Colon, unspecified

189

1107

1.71

10.99

1.3

0.21

0.30

nmol/l

0.52

Peripheral artery disease

319

1700

1.52

10.99

1.3

0.20

0.29

nmol/l

0.90

139

Thoracic aortic aneurysm

107

527

2.05

10.94

1.3

0.12

0.32

nmol/l

—

Stroke, including SAH

502

2676

1.39

10.93

1.4

1.3

0.22

0.25

nmol/l

0.22

207

Oxicams

185

598

1.77

10.92

1.3

0.24

0.25

nmol/l

0.03

Other disorders of gingiva or/and edentulous alveolar ridge

175

2.91

10.89

1.6

1.2

0.16

0.19

nmol/l

—

Chronic periapical parodontitis

174

1004

1.75

10.89

1.2

1.3

0.19

0.26

nmol/l

0.45

Dental caries 3 and operation codes

777

3041

1.31

10.88

1.3

0.27

0.25

nmol/l

0.14

207

Menorrhagia

313

1128

1.54

10.85

1.3

0.20

nmol/l

0.00

Ventral hernia

201

1208

1.68

10.83

1.4

1.3

0.14

0.22

nmol/l

1.15

Pregnancy hypertension

364

2250

1.47

10.75

1.2

1.3

0.25

0.23

nmol/l

0.10

116

Other disorders of white blood cells

210

2.71

10.74

1.2

0.16

0.42

nmol/l

—

Artificial joint operation, meniscal resection

762

3898

1.30

10.58

1.2

1.3

0.27

0.23

nmol/l

0.17

273

Missing teeth due to accident, extraction or parodontitis

106

528

2.03

10.54

1.3

1.2

0.11

0.23

nmol/l

—

Stroke, excluding SAH

471

2511

1.40

10.53

1.4

1.3

0.24

0.25

nmol/l

0.10

195

Dental operations, only avohilmo

597

2256

1.36

10.51

1.3

0.25

0.27

nmol/l

0.14

172

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

834

4574

1.28

10.40

1.3

0.25

0.24

nmol/l

0.08

273

Vascular disorders of the intestines

202

2.71

10.38

1.2

1.3

0.16

0.39

nmol/l

—

Nontoxic goitre/thyroid nodule

272

1778

1.54

10.35

1.3

0.29

0.23

nmol/l

0.25

118

Dental pulpitis 2, only avohilmo

603

2287

1.35

10.31

1.3

0.27

0.26

nmol/l

0.05

167

Trochanteric bursitis

124

657

1.91

10.31

1.2

1.3

0.31

0.33

nmol/l

0.04

Benign neoplasm: Rectum, anus and anal canal

167

970

1.74

10.25

1.5

1.3

0.15

0.26

nmol/l

1.35

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

118

3.30

10.21

1.2

0.12

0.53

nmol/l

—

Inflammatory disease of uterus

132

717

1.86

10.17

1.2

0.12

0.29

nmol/l

—

Nontoxic multinodular goitre

179

1064

1.70

10.11

1.3

0.32

0.25

nmol/l

0.16

Dental operations

557

2100

1.37

10.09

1.3

0.23

0.28

nmol/l

0.37

158

Dental pulpitis 2

587

2228

1.35

10.04

1.3

0.27

0.26

nmol/l

0.05

159

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

299

2003

1.50

10.02

1.3

0.22

0.24

nmol/l

0.09

102

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

464

3315

1.38

10.02

1.2

1.3

0.29

0.22

nmol/l

0.50

197

Bacterial infection, other or unspecified

404

2582

1.42

10.02

1.4

1.3

0.20

0.27

nmol/l

0.72

187

Benign neoplasm: Transverse colon

444

2.10

10.01

1.4

1.3

0.30

0.33

nmol/l

—

Other specified/unspecified arthritis

224

1413

1.60

9.97

1.2

1.3

0.21

0.28

nmol/l

0.35

Dental caries 3, only avohilmo

711

2775

1.31

9.97

1.3

0.25

0.26

nmol/l

0.06

197

Dental caries, including avohilmo

660

2551

1.33

9.90

1.3

0.25

0.26

nmol/l

0.11

180

Allergic conjunctivitis

487

3521

1.37

9.85

1.2

1.3

0.29

0.22

nmol/l

0.52

205

Disorders of choroid and retina

650

3606

1.32

9.84

1.3

0.21

0.24

nmol/l

0.42

266

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

208

1295

1.61

9.77

1.3

1.2

0.17

0.25

nmol/l

0.82

Dental caries 1

659

2554

1.32

9.70

1.3

0.25

0.26

nmol/l

0.11

180

Other arthritis (FG)

255

1668

1.54

9.69

1.2

1.3

0.20

0.25

nmol/l

0.25

116

COPD-related respiratory insufficiency

410

2.12

9.64

1.4

1.2

0.20

0.34

nmol/l

—

Other diseases of blood and blood-forming organs, wide

184

1116

1.66

9.64

1.4

1.3

0.15

0.27

nmol/l

1.58

Other postsurgical states

252

2.46

9.63

1.6

1.3

—

0.38

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

229

2.33

9.60

1.6

1.2

0.15

0.14

nmol/l

—

Gout, FINNGEN

199

1232

1.63

9.59

1.2

1.3

0.25

0.31

nmol/l

0.26

109

Conjunctivitis (acute, non atopic)

230

1469

1.57

9.58

1.3

1.2

0.17

0.21

nmol/l

—

Dental caries 1, only avohilmo

671

2614

1.32

9.56

1.3

0.25

0.26

nmol/l

0.08

188

Combinations of oral blood glucose lowering drugs

215

1360

1.59

9.49

1.3

0.18

0.27

nmol/l

1.12

103

Haemorrhage, not elsewhere classified

3.43

9.48

1.4

1.2

0.18

0.21

nmol/l

—

Fissure and fistula of anal and rectal regions

187

1145

1.64

9.43

1.2

1.3

0.12

0.26

nmol/l

2.04

Other acute lower respiratory infections

406

2782

1.40

9.42

1.3

0.15

0.25

nmol/l

2.36

175

Paracetamol of NSAID medication

130

346

1.90

9.42

1.3

1.2

0.44

0.23

nmol/l

—

Sicca syndrome [Sjögren]

455

2.05

9.41

1.3

1.2

0.16

0.43

nmol/l

—

Primary gonarthrosis, bilateral

405

2542

1.40

9.36

1.2

1.3

0.17

0.24

nmol/l

1.53

214

Dental caries 3

693

2719

1.31

9.36

1.3

0.25

0.26

nmol/l

0.08

189

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

390

2.13

9.29

1.2

0.10

0.38

nmol/l

—

Gout, idiopatic and unspecified

169

1013

1.68

9.28

1.2

1.3

0.26

0.35

nmol/l

0.28

Venous thromboembolism

418

2939

1.39

9.25

1.3

0.17

0.26

nmol/l

1.38

209

Gingival hyperplasia

110

3.25

9.23

1.6

1.2

0.16

0.21

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

128

711

1.82

9.21

1.2

1.3

0.12

0.33

nmol/l

—

Neuralgia and neuritis, unspecified

210

2.56

9.16

1.2

1.3

0.54

0.51

nmol/l

—

Laparoscopic right hemicolectomy

217

2.53

9.08

1.3

0.42

0.46

nmol/l

—

Spondylolisthesis/Spondylolysis

149

869

1.73

9.07

1.2

1.3

0.22

0.21

nmol/l

0.03

Benign neoplasm: Stomach

490

1.98

9.01

1.3

0.37

0.35

nmol/l

0.05

Cystic kidney disease

117

3.14

9.00

1.5

1.3

0.32

0.53

nmol/l

—

Benign neoplasm: Caecum

456

2.02

8.99

1.3

0.13

0.33

nmol/l

—

Benign neoplasm: Rectum

147

857

1.73

8.98

1.4

1.3

0.15

0.27

nmol/l

1.18

Other and unspecified nerve root and plexus disorders, also in other diseases

159

947

1.69

8.97

1.2

1.3

0.26

nmol/l

0.00

Benign neoplasm: Colon, unspecified

189

1177

1.62

8.95

1.3

0.21

0.27

nmol/l

0.37

Leiomyoma of uterus

412

1664

1.40

8.92

1.3

1.2

0.37

0.22

nmol/l

0.68

Benign neoplasm: Kidney

139

2.94

8.92

1.5

1.3

0.22

0.50

nmol/l

—

Benign neoplasm: Kidney

139

2.94

8.92

1.5

1.3

0.22

0.56

nmol/l

—

Neuromuscular dysfunction of bladder

397

2.09

8.89

1.3

0.31

0.30

nmol/l

—

Diseases of external ear

262

1758

1.50

8.87

1.3

0.22

0.26

nmol/l

0.22

121

Type 1 diabetes

192

1201

1.61

8.85

1.4

1.2

0.15

0.31

nmol/l

1.49

Other specified/unspecified soft tissue disorders

196

2.59

8.84

1.4

1.3

—

0.47

nmol/l

—

Ischaemic Stroke, excluding all haemorrhages

425

2339

1.38

8.83

1.3

0.24

0.25

nmol/l

0.02

184

Retention of urine

222

1210

1.56

8.82

1.3

0.39

0.28

nmol/l

0.29

100

Exposure to other specified factors

597

4304

1.30

8.82

1.3

0.21

0.25

nmol/l

0.32

263

Lateral epicondylitis

118

649

1.83

8.80

1.2

1.3

0.13

0.31

nmol/l

—

Dental caries 1 and operation codes

726

2903

1.29

8.77

1.3

0.23

0.25

nmol/l

0.13

201

Hernia of abdominal wall

355

2529

1.41

8.75

1.3

0.14

0.27

nmol/l

2.44

188

Other disorders of eyelid

340

2321

1.42

8.73

1.2

1.3

0.22

0.26

nmol/l

0.28

197

Mental disorders, not otherwise specified

380

2.10

8.72

1.2

1.3

0.15

0.38

nmol/l

—

Leiomyoma of uterus

558

2397

1.33

8.71

1.3

1.2

0.38

0.20

nmol/l

1.07

140

Postprocedural disorders of nervous system

310

2.22

8.60

1.3

0.14

0.56

nmol/l

—

Triptan medication for migraine, min. 3 purchases

462

2705

1.35

8.58

1.3

0.15

0.23

nmol/l

1.95

145

Congenital malformations of the urinary system

224

2.44

8.50

1.4

1.3

0.32

0.39

nmol/l

—

Disorders of lens

557

2670

1.32

8.48

1.3

0.21

0.23

nmol/l

0.08

204

Presence of other functional implants

445

2323

1.36

8.48

1.3

0.15

0.26

nmol/l

2.15

190

Oter anti-inflammatory and antirheumatic agents, non-steroids

166

547

1.69

8.48

1.2

1.3

0.23

0.24

nmol/l

0.05

Procreative management

271

1553

1.48

8.44

1.9

1.3

0.17

0.24

nmol/l

0.78

Other disorders of bone

169

1040

1.64

8.43

1.3

1.2

0.19

0.27

nmol/l

0.48

Other and unspecified visual disturbances

419

2.03

8.43

1.2

1.3

0.16

0.35

nmol/l

—

Voice disturbances

221

1448

1.54

8.42

1.3

0.16

0.25

nmol/l

1.05

102

Metatarsalgia

440

2.00

8.39

1.3

0.31

0.41

nmol/l

—

Propionic acid derivatives

217

692

1.58

8.37

1.2

1.3

0.39

0.24

nmol/l

—

COPD, hospital admission 2, with asthma infections

218

1210

1.54

8.36

1.3

0.19

0.32

nmol/l

0.92

Otalgia

347

2.13

8.34

1.4

1.3

0.12

0.40

nmol/l

—

Bipolar affective disorders

156

944

1.66

8.31

1.2

1.3

0.18

0.30

nmol/l

1.10

Symptoms and signs involving speech and voice

269

1842

1.47

8.27

1.3

0.17

0.23

nmol/l

1.06

126

Contact with and exposure to communicable diseases

241

1608

1.50

8.25

1.3

0.23

nmol/l

0.04

Chronic laryngitis and laryngotracheitis

118

664

1.79

8.20

1.3

0.19

0.27

nmol/l

—

Unspecific neurodegenerative disorder

104

1286

0.55

8.18

1.2

1.3

0.18

0.34

nmol/l

—

101

Asthma, hospital admissions 3, pneumonia

263

1794

1.47

8.17

1.4

1.3

0.17

0.24

nmol/l

1.19

127

Asthma-related pneumonia or sepsis

263

1794

1.47

8.17

1.4

1.3

0.17

0.24

nmol/l

1.19

127

Budesonide

115

643

1.80

8.16

1.3

0.20

0.37

nmol/l

0.81

Emotionally unstable personality disorder

101

543

1.88

8.13

1.1

1.3

0.10

0.28

nmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

236

1582

1.50

8.07

1.4

1.3

0.18

0.27

nmol/l

0.94

118

Glomerulonephritis

433

1.98

8.05

1.1

1.3

0.10

0.36

nmol/l

—

Asthma-related pneumonia

262

1792

1.47

8.04

1.4

1.3

0.17

0.24

nmol/l

1.19

127

Cardiac murmurs and other cardiac sounds

322

2.14

7.99

1.3

0.10

0.36

nmol/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

292

2032

1.43

7.94

1.2

1.3

0.28

0.25

nmol/l

0.12

130

Other enthesopathy of foot (+metatarsalgia)

477

1.93

7.94

1.3

0.31

0.42

nmol/l

—

Other shoulder lesions

401

2.02

7.93

1.2

1.3

0.13

0.40

nmol/l

—

Special screening examination for infectious and parasitic diseases

165

759

1.63

7.86

1.3

0.13

0.30

nmol/l

—

Gout, unspecified

137

814

1.69

7.86

1.2

1.3

0.25

0.30

nmol/l

0.12

Localized swelling, mass and lump of skin and subcutaneous tissue

246

1675

1.48

7.81

1.4

1.2

0.12

0.24

nmol/l

3.34

115

Cerebral palsy and other paralytic syndromes

502

1.89

7.75

1.3

0.32

0.37

nmol/l

—

Diseases of appendix

608

4344

1.28

7.75

1.2

1.3

0.24

nmol/l

0.00

281

Direct fill therapy

114

647

1.78

7.72

1.3

0.13

0.32

nmol/l

—

Atopic dermatitis

443

2840

1.34

7.70

1.2

1.3

0.30

0.22

nmol/l

0.25

162

Gout, strict definition

118

677

1.76

7.69

1.2

1.3

0.15

0.31

nmol/l

1.11

Other and unspecified drugs and medicaments

372

2.04

7.69

1.2

1.3

0.10

0.37

nmol/l

—

Colectomy operation

132

782

1.70

7.68

1.4

1.3

0.34

0.27

nmol/l

—

Familial hypercholesterolemia

108

604

1.80

7.68

1.4

1.3

0.14

0.33

nmol/l

1.38

Deviated nasal septum

251

1721

1.46

7.67

1.3

0.16

0.28

nmol/l

1.51

126

Appendicitis, broad definition

602

4317

1.28

7.67

1.2

1.3

0.24

nmol/l

0.00

280

Hyperplasia of prostate

235

892

1.51

7.60

1.4

1.3

0.29

0.28

nmol/l

0.02

Diseases of male genital organs

364

1326

1.39

7.56

1.3

1.4

0.12

0.27

nmol/l

1.95

105

Cellulitis

168

1062

1.59

7.56

1.2

1.3

0.22

0.25

nmol/l

0.19

Other abnormal uterine and vaginal bleeding

195

899

1.56

7.55

1.2

0.19

0.21

nmol/l

—

Pulmonary embolism

217

1451

1.50

7.55

1.4

1.3

0.19

0.29

nmol/l

0.88

104

Superficial injury of lower leg

194

1268

1.54

7.53

1.2

1.3

0.19

0.25

nmol/l

0.49

Pulmonary heart disease

217

1452

1.50

7.53

1.4

1.3

0.19

0.29

nmol/l

0.86

105

Alzheimer disease, including avohilmo

1078

0.53

7.51

1.2

1.3

0.14

0.28

nmol/l

—

Other bacterial intestinal infections

134

803

1.68

7.47

1.3

0.12

0.27

nmol/l

2.00

Endometriosis of ovary

144

877

1.65

7.47

1.3

0.25

0.21

nmol/l

—

Other diseases of oesophagus

376

2.01

7.45

1.3

1.2

0.13

0.32

nmol/l

1.47

Noninflammatory disorders of female genital tract

351

1268

1.40

7.45

1.2

1.3

0.23

0.20

nmol/l

0.16

Any dementia

1205

0.56

7.44

1.2

1.3

0.25

nmol/l

0.04

Appendectomy

534

3995

1.29

7.42

1.3

0.17

0.23

nmol/l

1.04

242

Type 1 diabetes, wide definition, subgroup 1

159

996

1.60

7.40

1.3

1.2

0.14

0.28

nmol/l

—

Early onset COPD

175

1123

1.57

7.39

1.2

1.3

0.15

0.27

nmol/l

1.27

Spondyloarthritis

137

828

1.66

7.39

1.3

0.12

0.29

nmol/l

—

Viral pneumonia (unknown virus, not influenza)

265

2.22

7.36

1.3

0.13

0.35

nmol/l

—

Female genital prolapse

253

995

1.48

7.36

1.3

0.14

0.20

nmol/l

—

Cerebral aneurysm, nonruptured

413

1.96

7.35

1.6

1.3

0.15

0.35

nmol/l

—

Senile cataract

503

2388

1.31

7.33

1.3

0.21

0.23

nmol/l

0.11

187

Problems related to lifestyle

428

1.93

7.27

1.3

0.12

0.33

nmol/l

—

Benign neoplasm: Sigmoid colon

136

825

1.66

7.26

1.5

1.2

0.18

0.32

nmol/l

0.99

Abnormal results of function studies

374

2.00

7.22

1.4

1.3

0.28

0.31

nmol/l

—

Acute appendicitis

563

4169

1.28

7.20

1.2

1.3

0.24

nmol/l

0.02

269

Restless leg syndrome

104

588

1.79

7.18

1.3

0.63

0.35

nmol/l

—

Benign neoplasm of urinary organs

187

2.44

7.12

1.4

1.3

0.22

0.48

nmol/l

—

Dementia, including avohilmo

139

1537

0.62

7.11

1.2

1.3

0.27

0.30

nmol/l

0.11

121

Coxarthrosis

378

1898

1.36

7.06

1.3

0.18

0.26

nmol/l

1.06

150

Diabetes insipidus

5.37

7.03

1.6

1.2

—

nmol/l

—

Otitis externa, unspecified

483

1.86

7.03

1.5

1.3

0.19

0.36

nmol/l

—

Benign lipomatous neoplasm

222

1515

1.47

7.03

1.3

1.2

0.15

0.27

nmol/l

1.62

109

Internal derangement of knee

289

2064

1.40

7.02

1.3

0.16

0.27

nmol/l

1.72

135

Deposits [accretions] on teeth

248

2.20

7.01

1.7

1.3

0.10

0.28

nmol/l

—

Benign neoplasm of urinary organs

189

2.42

6.97

1.4

1.3

0.22

0.44

nmol/l

—

Presence of cardiac and vascular implants and grafts

317

1736

1.39

6.96

1.3

0.21

0.28

nmol/l

0.43

154

Other specified/unspecified bacterial intestinal infections

285

2.13

6.94

1.5

1.3

0.12

0.39

nmol/l

—

Type 1 diabetes, wide definition

164

1053

1.56

6.90

1.3

1.2

0.14

0.28

nmol/l

—

Other and unspecified disorders of white blood cells

154

2.57

6.88

1.3

1.2

0.16

0.46

nmol/l

—

Impingement syndrome of shoulder

192

1279

1.51

6.87

1.3

0.29

0.28

nmol/l

—

Benign leiomyoma with endometriosis

145

909

1.61

6.83

1.3

1.2

0.50

0.24

nmol/l

—

Chronic diseases of tonsils and adenoids

653

3302

1.25

6.83

1.3

0.23

nmol/l

0.00

191

Mental and behavioural disorders due to alcohol, excluding acute intoxication

327

2399

1.37

6.82

1.2

1.3

0.16

0.27

nmol/l

1.88

160

Other disorders of breast

117

696

1.70

6.78

1.2

0.28

0.31

nmol/l

—

Viral pneumonia

547

1.79

6.77

1.3

0.17

0.34

nmol/l

—

Sequelae of cerebrovascular disease

236

1436

1.45

6.77

1.3

0.14

0.31

nmol/l

1.81

109

Dementia

126

1409

0.61

6.77

1.2

1.3

0.25

0.31

nmol/l

0.27

106

Gonarthrosis, primary, with knee surgery

423

2630

1.32

6.76

1.2

1.3

0.33

0.24

nmol/l

0.21

218

Emphysema

223

2.26

6.74

1.7

1.3

0.24

0.36

nmol/l

—

All influenza

179

1180

1.52

6.72

1.4

1.3

0.16

0.26

nmol/l

1.40

Injuries to unspecified part of trunk, limb or body region

420

1.90

6.67

1.5

1.3

0.13

0.36

nmol/l

—

Disorders of sclera, cornea, iris and ciliary body

424

3248

1.31

6.65

1.3

0.31

0.24

nmol/l

0.29

214

Abnormal serum enzyme levels

196

1304

1.49

6.62

1.3

0.15

0.31

nmol/l

1.86

119

Acute appendicitis, no complications

438

3364

1.30

6.60

1.2

1.3

0.23

nmol/l

0.00

204

Heart failure and bmi 25plus

275

1350

1.41

6.58

1.3

0.14

0.29

nmol/l

1.51

103

187

1104

1.51

6.57

1.2

1.3

0.16

0.24

nmol/l

1.19

Vitamin deficiency

182

2.39

6.56

1.3

0.16

0.45

nmol/l

—

Vitamin deficiency, wide

182

2.39

6.56

1.3

0.16

0.45

nmol/l

—

Diabetic nephropathy

136

838

1.62

6.53

1.4

1.3

0.16

0.25

nmol/l

0.51

Monoamine oxidase A inhibitors

105

613

1.73

6.52

1.4

1.3

0.14

0.29

nmol/l

—

Other benign neoplasms of skin

266

1870

1.40

6.46

1.3

1.2

0.28

0.25

nmol/l

0.10

129

Alcohol use disorder, Swedish definition

401

2838

1.32

6.46

1.2

1.3

0.15

0.28

nmol/l

2.36

185

Fracture of lower leg, including ankle

431

3312

1.30

6.42

1.2

1.3

0.22

0.26

nmol/l

0.29

214

Dialysis

130

2.65

6.41

1.2

1.3

0.30

0.48

nmol/l

—

Other and unspecified tonsillitis

245

1466

1.42

6.39

1.4

1.3

0.27

0.21

nmol/l

0.29

Spondylopathies (FG)

114

685

1.68

6.37

1.3

1.2

0.12

0.33

nmol/l

—

Candidiasis

106

625

1.71

6.36

1.3

0.34

0.33

nmol/l

—

Parodontitis or/and operation codes

545

2555

1.27

6.36

1.3

0.18

0.20

nmol/l

0.16

143

Mental and behavioural disorders due to alcohol

368

2707

1.33

6.35

1.2

1.3

0.16

0.28

nmol/l

2.16

177

Other blood glucose lowering drugs, excl. Insulins

124

763

1.64

6.32

1.3

1.2

0.23

0.28

nmol/l

—

Aneurysms, operations, SAH

127

787

1.62

6.30

1.5

1.3

0.14

0.24

nmol/l

—

Achilles tendinitis

465

1.82

6.28

1.2

1.3

0.10

0.28

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

169

947

1.52

6.25

1.3

0.15

0.37

nmol/l

1.69

Diabetic nephropathy, excluding more controls

133

693

1.62

6.25

1.4

0.16

0.29

nmol/l

0.65

Later onset COPD

171

885

1.52

6.25

1.3

0.18

0.36

nmol/l

1.04

Otitis externa

169

1120

1.52

6.24

1.3

0.28

0.27

nmol/l

—

Injury of unspecified body region

304

2.03

6.24

1.5

1.3

0.13

0.39

nmol/l

—

Other menopausal disorders

236

947

1.44

6.23

1.3

0.14

0.20

nmol/l

0.75

Impotence

168

2.41

6.22

1.3

1.4

0.14

0.31

nmol/l

—

Persistent mood disorders

154

1003

1.54

6.17

1.3

0.16

0.29

nmol/l

1.49

TMD related operations

138

878

1.58

6.15

1.3

0.16

0.27

nmol/l

—

Degeneration of macula and posterior pole

331

2037

1.34

6.12

1.2

1.3

0.16

0.28

nmol/l

1.86

170

Excessive attrition of teeth

310

1231

1.37

6.08

1.3

0.23

0.19

nmol/l

0.31

420

2986

1.30

6.05

1.2

1.3

0.15

0.27

nmol/l

2.37

195

Mental and behavioural disorders due to sedatives or hypnotics

301

2.02

6.05

1.4

1.3

0.14

0.35

nmol/l

—

Other female pelvic inflammatory diseases

148

961

1.55

6.04

1.3

1.2

0.22

0.27

nmol/l

—

Viral infections of the central nervous system

315

1.99

6.03

1.4

1.3

0.15

0.39

nmol/l

—

Other dialysis

100

2.85

6.03

1.2

1.4

0.20

0.35

nmol/l

—

Peripheral arterial reconstruction

105

627

1.68

6.02

1.3

0.18

0.33

nmol/l

1.21

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

254

2.10

6.00

1.2

0.25

0.33

nmol/l

—

Diseases of the myoneural junction and muscle

546

1.74

5.99

1.4

1.3

0.45

0.31

nmol/l

0.19

Vasomotor and allergic rhinitis

286

2072

1.37

5.98

1.2

1.3

0.21

0.24

nmol/l

0.22

110

Bacterial intestinal infections, IBD co-morbidities

130

821

1.59

5.98

1.3

0.12

0.24

nmol/l

2.39

DVT of lower extremities and pulmonary embolism

295

2174

1.36

5.97

1.4

1.3

0.18

0.28

nmol/l

0.97

166

Degenerative diseases of the nervous system

1073

0.57

5.94

1.2

1.3

0.18

0.26

nmol/l

—

Other diseases of pleura

304

1999

1.35

5.91

1.3

0.22

0.28

nmol/l

0.31

160

282

1950

1.37

5.89

1.3

0.18

0.30

nmol/l

1.32

147

Other and/or unspecified nontoxic goitre

410

1.85

5.88

1.5

1.3

0.22

0.38

nmol/l

—

Atopic dermatitis, strict definition with reimbursement

224

1538

1.42

5.87

1.2

1.3

0.39

0.24

nmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

202

692

1.47

5.79

1.3

0.44

0.24

nmol/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

182

1246

1.47

5.77

1.3

0.15

0.25

nmol/l

1.35

Coxarthrosis [arthrosis of hip](FG)

406

2270

1.30

5.77

1.3

0.18

0.24

nmol/l

0.78

182

Dislocation, sprain and strain of joints and ligaments of knee

472

3471

1.27

5.73

1.2

1.3

0.15

0.24

nmol/l

2.57

210

Superficial injury of ankle and foot

501

1.75

5.72

1.3

0.40

0.37

nmol/l

—

Other diseases of lip and oral mucosa

125

793

1.59

5.67

1.3

0.13

0.25

nmol/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

122

746

1.59

5.60

1.5

1.3

0.31

nmol/l

—

Injuries to the thorax

314

2370

1.33

5.56

1.3

0.29

0.27

nmol/l

0.04

166

Postmenopausal bleeding

225

872

1.42

5.54

1.2

1.3

0.15

0.21

nmol/l

0.89

Non-allergic asthma (mode), excluding more controls

136

876

1.55

5.53

1.2

0.16

0.28

nmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

260

1806

1.37

5.51

1.3

0.18

0.31

nmol/l

1.18

137

In situ neoplasms

247

1720

1.38

5.43

1.3

1.2

0.12

0.28

nmol/l

2.90

116

Benign neoplasm: Sigmoid colon

136

889

1.54

5.43

1.5

1.3

0.18

0.27

nmol/l

0.66

Acute pharyngitis

105

641

1.64

5.42

1.4

1.3

0.12

0.20

nmol/l

—

Superficial injury of wrist and hand

149

995

1.51

5.38

1.2

1.3

0.52

0.28

nmol/l

—

Fracture of foot, except ankle

180

1248

1.45

5.37

1.2

1.3

0.19

0.25

nmol/l

0.64

Acute pancreatitis

137

900

1.53

5.34

1.2

1.3

0.19

0.25

nmol/l

0.57

131

806

1.55

5.31

1.3

0.16

0.26

nmol/l

1.13

Duodenal ulcer

387

1.82

5.31

1.5

1.2

0.43

0.28

nmol/l

0.22

Mycoses

193

1359

1.43

5.30

1.4

1.3

0.30

0.24

nmol/l

0.29

Crohn disease

604

1.65

5.30

1.2

1.3

0.17

0.33

nmol/l

—

Polymyalgia rheumatica

574

1.67

5.28

1.2

1.3

0.10

0.30

nmol/l

—

Benign leiomyoma with endometriosis

145

969

1.51

5.25

1.3

0.50

0.24

nmol/l

—

Ménière disease

470

1.74

5.24

1.3

0.16

0.36

nmol/l

—

Fracture of rib(s), sternum and thoracic spine

202

1437

1.41

5.24

1.3

0.34

0.26

nmol/l

0.24

104

Tuberous sclerosis 1

14.72

5.21

2.1

1.7

—

Actinic keratosis

248

1733

1.36

5.20

1.3

0.13

0.32

nmol/l

2.71

130

Coagulation defects, purpura and other haemorrhagic conditions

137

907

1.52

5.17

1.3

0.28

0.30

nmol/l

—

438

3118

1.26

5.17

1.2

1.3

0.15

0.27

nmol/l

2.37

197

Benign intracranial hypertension

4.31

5.13

1.2

—

nmol/l

—

Other peripheral vertigo

436

1.76

5.13

1.3

0.12

0.37

nmol/l

—

Spinal osteochondrosis

4.29

5.12

1.6

—

0.58

—

Vitamin B12 deficiency anaemia

451

1.74

5.11

1.3

0.47

0.34

nmol/l

—

Erosion of teeth, including avohilmo

148

964

1.49

5.09

1.3

1.2

0.18

0.19

nmol/l

—

Other disorders of the musculoskeletal system and connective tissue

111

705

1.59

5.07

1.1

1.3

0.42

0.30

nmol/l

—

Alcohol use disorder, ICD-based

293

2223

1.32

5.06

1.2

1.3

0.16

0.24

nmol/l

1.60

145

Delirium, not induced by alcohol and other psychoactive substances

415

1.77

5.05

1.2

1.3

0.42

0.31

nmol/l

—

Superficial injury of abdomen, lower back and pelvis

108

683

1.59

5.02

1.3

0.13

0.37

nmol/l

—

Postmenopausal atrophic vaginitis

208

891

1.41

5.01

1.2

1.3

0.24

0.20

nmol/l

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

286

1898

1.33

5.01

1.6

1.2

0.40

0.26

nmol/l

0.36

139

Other orthopaedic follow-up care

246

2.01

5.00

1.3

0.15

0.42

nmol/l

—

Other symptoms and signs involving general sensations and perceptions

123

2.47

4.98

1.2

0.16

0.64

nmol/l

—

Inflammatory bowel disease

236

1739

1.36

4.97

1.3

0.21

0.22

nmol/l

0.07

102

Other specified and unspecified personality disorders

403

1.78

4.97

1.2

1.3

0.13

0.40

nmol/l

—

Benign neoplasm of mouth and pharynx

493

1.70

4.95

1.4

1.2

0.19

0.35

nmol/l

—

Non-allergic asthma (mode)

136

900

1.50

4.93

1.2

1.3

0.16

0.27

nmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

494

1.69

4.92

1.3

1.2

0.18

0.35

nmol/l

—

Radial styloid tenosynovitis [de Quervain]

241

2.01

4.90

1.3

0.10

0.51

nmol/l

—

Poisoning by drugs, medicaments and biological substances

179

1263

1.42

4.90

1.3

1.2

0.14

0.28

nmol/l

1.83

COPD, hospital admissions 1, only main diagnosis

223

1386

1.38

4.89

1.2

1.3

0.18

0.31

nmol/l

1.05

114

Medical abortion

529

2335

1.23

4.82

1.3

1.2

0.13

0.23

nmol/l

3.13

131

Unspecified fall

344

2665

1.28

4.80

1.2

1.3

0.24

0.25

nmol/l

0.05

178

Any dementia, excluding more controls

1028

0.63

4.80

1.2

1.3

0.25

0.36

nmol/l

—

ILD medications: azathioprine

113

732

1.55

4.75

1.4

1.3

0.29

0.35

nmol/l

—

Injuries to the shoulder and upper arm

634

4433

1.20

4.72

1.3

0.16

0.25

nmol/l

2.15

290

Trigeminal neuralgia

252

1.96

4.70

1.2

1.3

0.14

0.48

nmol/l

—

Disorders of breast

398

2939

1.26

4.69

1.3

1.2

0.25

0.21

nmol/l

0.17

157

Azathioprine

113

735

1.55

4.68

1.4

1.3

0.29

0.35

nmol/l

—

Chronic periodontitis

104

664

1.58

4.67

1.5

1.3

0.14

0.18

nmol/l

0.65

Sub-endpoint used in defining T1D endpoints

204

1461

1.38

4.65

1.4

1.3

0.14

0.24

nmol/l

1.73

Benign lipomatous neoplasm

222

1640

1.36

4.64

1.3

0.15

0.23

nmol/l

1.27

117

Heart failure and coronary heart disease

192

1026

1.40

4.63

1.3

0.14

0.35

nmol/l

1.80

Colonic or urogenital fistula

199

1446

1.38

4.62

1.2

1.3

0.12

0.24

nmol/l

2.95

103

Other/unspecified enthesopathies, not elsewhere classified

369

1.77

4.58

1.1

1.3

0.11

0.39

nmol/l

—

Disorders of continuity of bone

444

1.70

4.57

1.2

1.3

0.50

0.40

nmol/l

—

Ulcer of lower limb, not elsewhere classified

582

1.61

4.56

1.2

1.3

0.15

0.32

nmol/l

1.40

Use of pramipexole

162

1142

1.43

4.51

1.2

1.3

0.50

0.24

nmol/l

1.23

Diseases of peritoneum

469

1.68

4.49

1.4

1.3

0.21

0.37

nmol/l

0.72

Preparatory care for dialysis

155

2.22

4.48

1.3

0.18

0.48

nmol/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

110

719

1.54

4.47

1.2

1.3

0.13

0.25

nmol/l

1.43

Poisoning by medicine

159

1120

1.43

4.44

1.3

0.14

0.27

nmol/l

1.63

Disorders of ocular muscles, binocular movement, accommodation and refraction

343

2687

1.27

4.40

1.3

0.32

0.21

nmol/l

0.33

157

Superficial injury of head

156

1097

1.43

4.39

1.1

1.3

0.33

0.27

nmol/l

0.14

Car occupant injured in other and unspecified transport accidents

137

941

1.46

4.39

1.3

0.12

0.29

nmol/l

—

Haemorrhage in early pregnancy

221

1609

1.35

4.35

1.1

1.3

0.16

0.25

nmol/l

—

Leisure time condition

125

846

1.49

4.32

1.2

1.3

0.17

0.29

nmol/l

—

Ovarian dysfunction

260

1.90

4.30

1.2

1.1

—

0.44

nmol/l

—

Thyrotoxicosis with diffuse goitre

105

686

1.54

4.30

1.2

1.3

0.11

0.31

nmol/l

—

Pre-eclampsia or poor fetal growth

228

1715

1.33

4.20

1.2

1.3

0.20

0.25

nmol/l

—

Barrett oesophagus

160

2.15

4.17

1.1

1.3

0.20

0.31

nmol/l

—

Olecranon bursitis

228

1.95

4.16

1.3

0.16

0.34

nmol/l

—

Polyp of the female genital tract

244

1071

1.33

4.14

1.2

0.13

0.20

nmol/l

1.16

Benign neoplasm: Ascending colon

558

1.59

4.13

1.6

1.3

0.28

0.30

nmol/l

—

Pre-eclampsia or eclampsia

171

1238

1.39

4.12

1.2

1.3

0.21

0.23

nmol/l

—

Disorders of refraction and accommodation

192

1411

1.36

4.10

1.3

1.2

0.19

0.24

nmol/l

0.27

Ganglion

151

1071

1.42

4.09

1.3

0.41

0.27

nmol/l

0.34

Zoster [herpes zoster]

123

840

1.47

4.09

1.3

0.15

0.27

nmol/l

—

Acute pancreatitis (for exclusion)

137

955

1.44

4.09

1.2

1.3

0.19

0.25

nmol/l

0.55

Blepharochalasis

216

1626

1.33

4.05

1.2

1.3

0.24

0.27

nmol/l

—

130

Trigger finger

104

688

1.52

4.05

1.2

1.3

0.13

0.31

nmol/l

—

Lesion of ulnar nerve

648

1.54

4.04

1.3

0.13

0.27

nmol/l

—

L04AA Selective immunosuppressants

163

1175

1.39

4.04

1.3

0.22

0.24

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

155

1108

1.41

4.03

1.3

0.22

0.26

nmol/l

0.35

Peritonsillar abscess

148

1050

1.42

4.01

1.2

1.3

0.17

0.23

nmol/l

—

Acne

407

1.68

4.00

1.2

1.3

—

0.38

nmol/l

—

Atopic dermatitis, strict definition

208

1529

1.34

3.99

1.2

0.46

0.24

nmol/l

—

Fracture of skull and facial bones

149

1060

1.41

3.98

1.2

1.3

0.32

0.27

nmol/l

0.20

Coeliac disease

579

1.56

3.98

1.3

0.15

0.29

nmol/l

—

Sulfonylureas

221

1331

1.33

3.95

1.4

1.3

0.18

0.28

nmol/l

1.16

107

Endometriosis ASRM stages 3,4

186

1375

1.36

3.95

1.2

0.24

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

206

1546

1.34

3.95

1.3

0.18

0.24

nmol/l

0.91

Melanocytic naevi

199

1486

1.34

3.95

1.4

1.2

0.26

0.29

nmol/l

0.17

Anterior Iridocyclitis

146

1037

1.41

3.95

1.3

0.18

0.26

nmol/l

0.55

Artificial joint re-operation

305

1.79

3.94

1.2

1.3

0.13

0.48

nmol/l

—

Acute and subacute iridocyclitis

138

971

1.43

3.94

1.3

0.18

0.25

nmol/l

0.35

Benign neoplasm: Skin of eyelid, including canthus

108

725

1.50

3.93

1.3

0.14

0.30

nmol/l

—

Benign neoplasm of mouth and pharynx

526

1.59

3.93

1.4

1.3

0.19

0.35

nmol/l

—

Allergic rhinitis

220

1652

1.32

3.92

1.2

1.3

0.14

0.23

nmol/l

—

Other benign neoplasms of skin

266

2070

1.29

3.92

1.3

0.28

0.24

nmol/l

0.14

156

Ulcerative colitis

174

1275

1.37

3.91

1.3

0.24

0.23

nmol/l

—

Nontoxic single thyroid nodule

358

1.72

3.90

1.3

0.22

0.42

nmol/l

—

Misadventures to patients during surgical and medical care

654

1.52

3.89

1.5

1.3

0.22

0.34

nmol/l

—

Fibroblastic disorders

149

1066

1.40

3.87

1.2

1.3

0.17

0.29

nmol/l

—

Other skin changes

114

777

1.47

3.86

1.2

1.3

0.16

0.31

nmol/l

—

L04AD Calcineurin inhibitors

505

1.60

3.85

1.3

0.23

0.33

nmol/l

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

294

1804

1.27

3.85

1.4

1.2

0.18

0.26

nmol/l

0.86

138

Fall on same level involving ice and snow

421

3460

1.22

3.84

1.3

0.28

0.25

nmol/l

0.14

223

Unspecified mental disorder

301

2385

1.27

3.83

1.2

1.3

0.17

0.22

nmol/l

1.07

134

Urethritis and urethral syndrome

2.57

3.82

1.5

1.2

—

0.75

nmol/l

—

Other fall from one level to another

148

1060

1.40

3.81

1.2

1.3

0.16

0.25

nmol/l

0.99

Supplementary factors related to causes of morbidity and mortality classified elsewhere

212

1608

1.32

3.80

1.3

0.29

0.21

nmol/l

0.25

Iridocyclitis

162

1181

1.38

3.77

1.3

0.18

0.22

nmol/l

0.28

In situ neoplasms

247

1916

1.29

3.76

1.3

0.13

0.24

nmol/l

3.30

133

Focal epilepsy

141

1005

1.41

3.75

1.3

0.19

0.27

nmol/l

0.56

Other disorders of conjunctiva

652

1.51

3.75

1.2

1.3

0.19

0.30

nmol/l

—

Pre-eclampsia superimposed on chronic hypertension

4.15

3.74

1.1

—

nmol/l

—

Other viral diseases

203

1530

1.33

3.73

1.2

1.3

0.13

0.23

nmol/l

1.88

Idiopathic gout

340

1.72

3.73

1.2

1.3

0.23

0.31

nmol/l

—

Other disorders of penis

355

1.70

3.73

1.2

1.3

0.22

0.24

nmol/l

—

Prolonged pregnancy

657

0.54

3.72

1.3

1.2

—

0.20

nmol/l

—

Complications predominantly related to the puerperium

200

1510

1.33

3.72

1.3

1.2

0.13

0.24

nmol/l

1.85

Other diseases of the respiratory system

123

858

1.44

3.70

1.4

1.3

0.19

0.29

nmol/l

—

Other respiratory disorders and diseases

123

858

1.44

3.70

1.4

1.3

0.19

0.29

nmol/l

—

Tobacco use

196

1.96

3.68

1.1

1.3

0.12

0.36

nmol/l

—

Injuries to the wrist and hand

759

4759

1.16

3.67

1.3

0.25

0.23

nmol/l

0.10

304

Umbilical hernia

177

1316

1.35

3.65

1.2

1.3

0.14

0.30

nmol/l

1.64

Chronic conjunctivitis

123

2.22

3.63

1.2

1.4

—

0.58

—

Pre-eclampsia

154

1123

1.38

3.61

1.1

1.3

0.21

0.24

nmol/l

—

Familial hypercholesterolemia, with ischemic heart disease

344

1.70

3.59

1.3

0.12

0.41

nmol/l

—

Chronic periodontitis, complicated

414

1.63

3.55

1.4

1.3

0.14

0.36

nmol/l

—

Glaucoma

388

2798

1.22

3.54

1.3

0.17

0.26

nmol/l

0.93

216

Viral infections characterized by skin and mucous membrane lesions

293

2339

1.26

3.53

1.3

0.12

0.23

nmol/l

4.20

153

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

208

1593

1.31

3.51

1.3

1.2

0.17

0.23

nmol/l

0.67

Focal epilepsy, strict definition

128

909

1.41

3.51

1.3

0.20

0.28

nmol/l

—

Inflammatory diseases of prostate (prostatitis)

462

1.59

3.51

1.3

0.14

0.33

nmol/l

—

Abscess of anal and rectal regions

339

1.69

3.50

1.3

0.13

0.32

nmol/l

—

Invasive ventilation

287

1.76

3.49

1.8

1.3

0.23

0.37

nmol/l

—

Benign neoplasm of bone and articular cartilage

370

1.66

3.48

1.2

0.16

0.42

nmol/l

—

Vulvovaginal ulceration/inflammation in other diseases

236

1.84

3.48

1.1

1.2

—

0.33

—

Acute peritonitis

237

1.83

3.43

1.5

1.2

0.23

0.39

nmol/l

0.55

Other and unspecified myopathies

334

1.69

3.41

1.4

1.3

0.56

0.33

nmol/l

—

Myocardial infarction, unclassifiable

119

746

1.43

3.41

1.4

1.3

0.23

0.28

nmol/l

—

Ovarian dysfunction, other/unspecified

5.17

3.41

1.3

1.2

—

Papulosquamous disorders

287

2298

1.25

3.41

1.3

0.16

0.23

nmol/l

0.95

166

Amenorrhoea

267

1.77

3.40

1.4

1.2

—

0.62

nmol/l

—

Nontraumatic intracranial haemmorrhage

121

856

1.42

3.40

1.4

1.3

0.11

0.25

nmol/l

—

Speech therapy

193

1472

1.32

3.38

1.3

0.15

0.25

nmol/l

—

105

Assault

603

1.50

3.36

1.2

1.3

0.26

0.24

nmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

203

1562

1.30

3.33

1.3

0.23

nmol/l

—

Infections with a predominantly sexual mode of transmission

215

1666

1.29

3.33

1.2

1.3

0.13

0.23

nmol/l

1.74

Type of accident

193

1476

1.31

3.32

1.2

1.3

0.16

0.21

nmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

122

869

1.41

3.31

1.3

0.20

0.28

nmol/l

—

Abnormal spermatozoa

422

1.60

3.31

1.4

1.3

0.24

0.28

nmol/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

376

2112

1.22

3.31

1.3

1.2

0.21

0.25

nmol/l

0.24

154

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

307

1.71

3.30

1.7

1.3

0.16

0.38

nmol/l

—

Benign neoplasm of bone and articular cartilage

376

1.63

3.29

1.2

1.3

0.16

0.35

nmol/l

—

Conductive and sensorineural hearing loss

582

3450

1.17

3.28

1.3

0.29

0.23

nmol/l

0.38

253

Amiodarone users

400

1.61

3.27

1.4

1.2

0.15

0.32

nmol/l

—

Myeloproliferative diseases

378

1.63

3.24

1.3

0.18

0.38

nmol/l

—

Thyroiditis

340

1.66

3.22

1.3

—

0.48

nmol/l

—

Cholecystitis

577

1.50

3.21

1.3

0.17

0.31

nmol/l

—

Disorders of puberty

3.61

3.20

1.3

—

nmol/l

—

Crohn's disease of small intestine

295

1.71

3.20

1.3

0.19

0.35

nmol/l

—

Pilonidal cyst

372

1.62

3.18

1.4

1.3

0.14

0.27

nmol/l

—

Alcohol-induced chronic pancreatitis

251

1.77

3.17

1.3

0.18

0.23

nmol/l

—

Calcific aortic valvular stenosis, operated

164

1208

1.33

3.16

1.2

1.3

0.12

0.34

nmol/l

—

102

Calcific aortic valvular stenosis

164

1208

1.33

3.16

1.2

1.3

0.12

0.34

nmol/l

—

102

Pleural effusion

613

1.47

3.13

1.4

1.3

0.11

0.28

nmol/l

—

Benign neoplasm: Ascending colon

597

1.48

3.13

1.6

1.3

0.27

0.32

nmol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

163

1207

1.33

3.05

1.2

1.3

0.12

0.34

nmol/l

—

102

Operations 2 for CAVS

163

1207

1.33

3.05

1.2

1.3

0.12

0.34

nmol/l

—

102

Methotrexate

104

733

1.43

3.04

1.2

1.3

0.24

0.34

nmol/l

—

Pregnancy with abortive outcome

527

2349

1.18

3.03

1.2

0.21

0.23

nmol/l

0.19

132

Scoliosis

338

1.64

3.03

1.4

1.3

0.27

0.38

nmol/l

—

All influenza (not pneumonia)

684

1.44

3.01

1.4

1.3

0.10

0.31

nmol/l

—

Hallux rigidus

104

735

1.42

3.00

1.2

1.3

0.11

0.32

nmol/l

—

Viral and other specified intestinal infections

127

906

1.37

3.00

1.3

1.2

0.13

0.30

nmol/l

—

Calcific aortic valvular stenosis, including rheumatic fever

163

1211

1.32

2.97

1.2

1.3

0.12

0.34

nmol/l

—

102

Atopic conjunctivitis

183

1.87

2.97

1.1

1.3

—

0.53

nmol/l

—

Follicular cysts of skin and subcutaneous tissue

126

922

1.37

2.96

1.2

1.3

0.10

0.26

nmol/l

—

Endocarditis

114

2.13

2.95

1.7

1.3

0.12

0.38

nmol/l

—

Diabetes mellitus in pregnancy

212

1075

1.28

2.95

1.2

1.3

0.16

0.18

nmol/l

—

D07AA Corticosteroids, weak (group I)

102

720

1.42

2.94

1.2

1.3

0.10

0.36

nmol/l

—

Other pleural conditions

372

1.59

2.94

1.2

1.3

0.34

0.27

nmol/l

—

Diseases of middle ear and mastoid

403

2774

1.19

2.94

1.4

1.3

0.17

0.22

nmol/l

0.88

156

Infective dermatitis

549

1.48

2.92

1.4

1.3

0.24

0.34

nmol/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

185

1419

1.29

2.91

1.4

1.2

0.13

0.26

nmol/l

—

Sensorineural hearing loss

541

3258

1.16

2.91

1.3

0.31

0.23

nmol/l

0.50

247

Traumatic subarachnoid haemorrhage

2.23

2.90

1.4

1.3

0.18

0.56

nmol/l

—

Atrophic disorders of skin

108

775

1.40

2.88

1.2

1.3

0.14

0.32

nmol/l

—

Striking against or struck by other objects

214

1693

1.27

2.87

1.2

1.3

0.56

0.24

nmol/l

—

Allergic urticaria

359

1.60

2.87

1.2

1.3

—

0.42

nmol/l

—

Fitting and adjustment of other devices

220

1624

1.26

2.86

1.3

0.34

0.25

nmol/l

0.43

126

Abnormal findings on antenatal screening of mother

297

1.66

2.86

1.0

1.2

—

0.18

nmol/l

—

Intussusception

2.32

2.86

1.1

1.2

—

0.80

nmol/l

—

Burns and corrosions confined to eye and internal organs

2.21

2.84

1.2

1.3

—

0.58

—

Polyglandular dysfunction, other/unspecified

9.44

2.84

3.2

1.2

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

143

1076

1.33

2.82

1.8

1.3

0.58

0.31

nmol/l

0.37

Medial epicondylitis

165

1.90

2.82

1.0

1.4

—

0.49

—

Other hearing loss

164

1237

1.31

2.81

1.3

0.26

0.34

nmol/l

—

Parkinson's disease, excluding more controls

476

1.50

2.80

1.5

1.3

0.75

0.22

nmol/l

3.44

Keratitis

243

1959

1.24

2.80

1.3

0.38

0.20

nmol/l

0.49

132

Perforation of tympanic membrane

457

1.52

2.79

1.3

0.14

0.38

nmol/l

—

Salpingitis and oophoritis

143

1079

1.33

2.78

1.2

1.3

0.23

0.24

nmol/l

—

Other cataract

301

1916

1.22

2.78

1.3

0.53

0.24

nmol/l

0.58

147

Benign neoplasm: Skin of eyelid, including canthus

108

780

1.39

2.78

1.3

0.14

0.29

nmol/l

—

Other contact dermatitis

386

1.56

2.77

1.2

1.3

0.24

0.42

nmol/l

—

Sequelae of injuries of lower limb

442

1.52

2.77

1.4

1.3

0.14

0.37

nmol/l

—

Preterm labour and delivery

200

1579

1.27

2.76

1.2

1.3

0.14

0.24

nmol/l

—

Benign neoplasm of ovary

132

986

1.35

2.76

1.3

1.2

0.48

0.27

nmol/l

—

Psoriasis

199

1572

1.27

2.74

1.3

0.15

0.23

nmol/l

1.79

111

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

114

835

1.37

2.70

1.4

1.3

0.19

0.29

nmol/l

—

Acne vulgaris

318

1.61

2.69

1.2

1.3

—

0.44

nmol/l

—

Other disorders of patella

123

913

1.35

2.68

1.2

1.3

0.16

0.27

nmol/l

—

Other maltreatment syndromes

133

1.97

2.66

1.3

0.14

0.50

nmol/l

—

Malignant neoplasm of breast, HER-positive

178

2228

0.79

2.65

1.4

1.3

0.19

0.22

nmol/l

—

145

Medicines for HER+ breast cancer

188

2310

0.79

2.65

1.4

1.3

0.19

0.23

nmol/l

—

148

Hypertrophy of breast in women and men

143

1088

1.32

2.64

1.2

1.3

0.29

0.26

nmol/l

—

Delayed puberty

4.74

2.61

1.3

—

nmol/l

—

Other bursopathies

614

1.42

2.58

1.3

0.31

nmol/l

—

Other viral diseases, not elsewhere classified

121

900

1.35

2.57

1.2

0.12

0.29

nmol/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

268

1.65

2.56

1.5

1.4

0.17

0.41

nmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

178

1.81

2.56

1.1

1.3

—

0.29

nmol/l

—

Other and unspecified local infections of skin and subcutaneous tissue

402

1.53

2.56

1.4

1.3

0.32

0.34

nmol/l

—

Parkinson's disease, strict definition, excluding more controls

426

1.50

2.54

1.4

1.3

0.83

0.22

nmol/l

3.70

Recurring oral aphthae, including avohilmo

667

1.40

2.53

1.3

0.12

0.32

nmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

110

811

1.36

2.53

1.6

1.3

0.62

0.32

nmol/l

0.31

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

155

714

1.31

2.50

1.4

1.3

0.14

0.24

nmol/l

0.73

Cardiomyopathies, Primary/intrinsic

494

1.46

2.49

1.4

1.3

0.20

0.52

nmol/l

0.94

Reimbursement for rheumatic diseases

423

3626

1.17

2.49

1.2

1.3

0.22

0.23

nmol/l

0.06

230

IBD patients in KELA-register

153

1189

1.29

2.44

1.3

0.22

0.25

nmol/l

0.16

Transplanted organ and tissue status

423

1.50

2.44

1.4

1.3

0.23

0.32

nmol/l

—

Presence of other devices

128

972

1.32

2.42

1.2

1.3

0.29

0.33

nmol/l

0.11

Impacted cerumen

416

1.50

2.41

1.3

0.16

0.38

nmol/l

—

Herpesviral [herpes simplex] infections

531

1.44

2.41

1.5

1.3

0.12

0.35

nmol/l

—

Peripheral artery operations in Hilmo

440

1.48

2.41

1.2

1.3

0.14

0.26

nmol/l

0.85

Fracture of lumbar spine and pelvis

129

981

1.32

2.40

1.2

1.3

0.16

0.26

nmol/l

1.19

Use of galantamine

208

0.38

2.40

1.5

1.2

—

0.34

nmol/l

—

Melanocytic naevi

199

1602

1.25

2.38

1.4

1.3

0.26

0.24

nmol/l

0.09

Malignant melanoma, excluding all cancers (controls excluding all cancers)

102

753

1.36

2.35

1.2

0.22

0.36

nmol/l

0.83

Injuries to the elbow and forearm

502

3964

1.15

2.34

1.3

0.17

0.22

nmol/l

1.05

237

Suicide or other Intentional self-harm

167

1321

1.27

2.33

1.3

1.2

0.17

0.24

nmol/l

0.75

Injury of muscle and tendon at shoulder and upper arm level

238

1958

1.22

2.33

1.2

1.3

0.18

0.29

nmol/l

1.33

150

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

160

762

1.28

2.33

1.4

1.2

0.14

0.23

nmol/l

0.71

Bursitis of shoulder

2.06

2.33

1.9

1.2

—

0.54

nmol/l

—

Volvulus

2.20

2.32

2.0

1.2

—

0.68

nmol/l

—

Crohn disease (strict definition, require KELA)

276

1.60

2.32

1.5

1.4

0.17

0.39

nmol/l

—

Patellar tendinitis

2.88

2.31

1.2

1.5

—

0.58

nmol/l

—

Crohn disease (strict definition, all UC cases excluded)

207

1.70

2.31

1.4

1.3

0.16

0.39

nmol/l

—

Malignant neoplasm of pancreas

207

1.70

2.30

2.0

1.2

0.16

0.42

nmol/l

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

4.79

2.30

2.7

1.5

—

Defect, injury or illness of neck

4.73

2.29

1.5

1.2

—

Diagnoses used for exclusion with ILD

160

1263

1.27

2.28

1.3

0.23

0.24

nmol/l

—

Hallux valgus (acquired)

243

1448

1.22

2.27

1.2

1.3

0.19

0.27

nmol/l

0.85

Other adrenocortical overactivity

3.98

2.27

1.1

1.3

—

Other specified/unspecified hearing loss

325

1.55

2.27

1.2

1.3

—

0.35

nmol/l

—

5-aminosalicylic acid

141

1097

1.29

2.26

1.2

1.3

0.28

nmol/l

—

Spermatocele

239

1.64

2.25

1.3

—

0.28

nmol/l

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

160

1224

1.27

2.24

1.2

0.23

0.28

nmol/l

—

Other other unspecified disorders of the circulatory system

142

1.85

2.24

1.3

1.2

—

0.43

nmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

179

1.74

2.23

1.6

1.3

—

0.40

nmol/l

—

Chondropathies

102

761

1.35

2.22

1.3

0.30

0.29

nmol/l

—

Tonsillectomy and adenotomy

401

2407

1.16

2.22

1.3

0.17

0.21

nmol/l

0.57

106

Schizophrenia or delusion, excluding more controls

186

1488

1.24

2.22

1.3

0.24

0.26

nmol/l

0.13

Other local infections of skin and subcutaneous tissue

441

1.46

2.21

1.3

1.2

0.29

0.33

nmol/l

—

Open wound of thorax

2.53

2.20

1.2

1.5

—

0.58

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

573

1.39

2.19

1.1

1.3

0.12

0.37

nmol/l

—

Rheumatoid arthritis

214

1594

1.22

2.18

1.2

1.3

0.18

0.29

nmol/l

1.12

113

Biological medication for rheuma

107

807

1.33

2.17

1.2

1.3

0.22

0.30

nmol/l

—

Mild or no visual impairment, binocular

4.40

2.17

1.0

1.3

—

Postprocedural musculoskeletal disorders, not elsewhere classified

297

1.56

2.17

1.1

1.3

0.62

0.43

nmol/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

436

1.45

2.14

1.3

0.12

0.34

nmol/l

—

Myocardial infarction, with ST-elevation

663

1.36

2.13

1.3

0.25

0.27

nmol/l

—

Puerperal sepsis

105

793

1.33

2.13

1.3

0.14

0.32

nmol/l

1.86

Subacute thyroiditis

160

1.77

2.10

1.2

—

0.41

nmol/l

—

Labour and delivery complicated by fetal stress [distress]

816

0.74

2.09

1.3

—

0.21

nmol/l

—

Suppurative and unspecified otitis media

234

1722

1.21

2.09

1.4

1.3

0.15

0.24

nmol/l

0.94

Congenital malformations of genital organs

419

1.45

2.09

1.3

1.2

—

0.56

nmol/l

—

Assault by bodily force

332

1.51

2.09

1.1

1.3

0.33

nmol/l

—

Non-small cell lung cancer

615

1.37

2.08

1.1

1.3

0.12

0.32

nmol/l

—

Epiphora

2.10

2.08

1.2

1.3

—

0.73

nmol/l

—

Other or unspecified common variable immunodeficiency

4.15

2.06

1.3

—

L02BG Aromatase inhibitors

150

1876

0.80

2.06

1.3

0.17

0.25

nmol/l

—

131

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

618

1.36

2.03

1.2

1.3

0.23

0.38

nmol/l

0.74

Endometriosis of intestine

2.53

2.02

1.0

1.1

—

Cicatricial alopecia [scarring hair loss]

2.87

2.02

1.3

—

nmol/l

—

Kela-code for severe mental illness

252

2120

1.19

2.00

1.2

1.3

0.18

0.24

nmol/l

1.00

118

Glaucoma suspect

237

1984

1.20

1.99

1.2

1.3

0.16

0.24

nmol/l

1.12

152

Other noninflammatory disorders of vagina

377

1.47

1.98

1.3

1.2

—

0.32

nmol/l

—

Acromegaly and pituitary gigantism

3.40

1.98

1.0

1.2

—

nmol/l

—

Diabetic retinopathy, excluding more controls

203

937

1.22

1.97

1.3

1.4

0.24

0.26

nmol/l

—

Asthma and opportunity respiratory infection

171

1.71

1.97

1.5

1.2

—

0.51

—

Female infertility

207

1051

1.22

1.97

1.2

1.3

0.20

nmol/l

—

Other and unspecified cicatricial alopecia

4.76

1.97

1.4

1.2

—

nmol/l

—

Other hypertrichosis

4.68

1.96

1.2

1.3

—

Hereditary hypogammaglobulinemia

3.88

1.96

1.2

1.1

—

Alcohol dependence

166

1344

1.24

1.96

1.2

1.3

0.17

0.28

nmol/l

1.33

Cardiomyopathy (excluding other)

529

1.39

1.95

1.4

1.3

0.20

0.36

nmol/l

0.66

Redundant prepuce, phimosis and paraphimosis

111

854

1.30

1.92

1.2

1.3

0.13

0.31

nmol/l

—

Lung cancer and mesothelioma

107

703

1.31

1.91

1.1

1.3

0.14

0.28

nmol/l

—

Melanocytic naevi of other and unspecified parts of face

251

1.56

1.90

1.3

—

0.45

nmol/l

—

Abrasion of teeth

184

1107

1.22

1.90

1.2

1.3

0.13

0.19

nmol/l

—

Tumor necrosis factor alpha inhibitors

714

1.32

1.87

1.2

1.3

0.24

0.31

nmol/l

—

Other conjunctival vascular disorders and cysts

2.00

1.86

1.2

—

0.50

nmol/l

—

Benign neoplasm: Retina

3.61

1.85

3.3

1.3

—

nmol/l

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

301

1.50

1.85

1.4

1.3

0.17

0.37

nmol/l

—

Inflammatory bowel disease, strict (require KELA)

153

1237

1.24

1.85

1.3

0.22

0.25

nmol/l

0.16

Nontoxic diffuse goitre

137

1.77

1.84

1.2

—

0.64

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

4.28

1.84

1.2

—

Benign neoplasm: Rectosigmoid junction

160

1.70

1.82

1.1

1.2

—

0.46

—

Benign neoplasm: Rectosigmoid junction

160

1.70

1.82

1.1

1.2

—

0.49

—

Phlebitis and thrombophlebitis (not including DVT)

147

1187

1.24

1.81

1.2

1.3

0.16

0.20

nmol/l

—

Flatulence and related conditions

2.79

1.80

1.8

1.1

—

Nonischemic cardiomyopathy

207

1.60

1.80

1.5

1.3

0.22

0.39

nmol/l

—

Male infertility

176

1.66

1.79

1.4

—

0.33

nmol/l

—

Use of disulfiram, acamprosate or naltrexone

394

1.43

1.79

1.1

1.3

0.14

0.21

nmol/l

—

Acute suppurative otitis media

161

1227

1.23

1.77

1.4

1.3

0.17

0.27

nmol/l

—

Other medical care

251

2088

1.18

1.76

1.3

0.40

0.23

nmol/l

0.31

149

Other and unspecified disorders of binocular movement

3.40

1.76

1.3

1.1

—

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

316

1874

1.16

1.75

1.3

1.2

0.20

0.26

nmol/l

0.44

141

Other specified/unspecified deforming dorsopathies

2.24

1.74

1.1

1.4

—

0.58

nmol/l

—

Attention to artificial openings

132

1.75

1.74

1.3

—

0.33

nmol/l

—

Benign neoplasm of ovary

132

1059

1.25

1.74

1.3

0.48

0.27

nmol/l

—

Malignant neoplasm of digestive organs

220

1827

1.19

1.73

1.4

1.3

0.18

0.29

nmol/l

0.98

153

Tetraplegia

2.97

1.73

1.3

1.2

—

nmol/l

—

Ectopic pregnancy

125

997

1.26

1.73

1.3

1.2

0.18

0.23

nmol/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

3.95

1.73

1.2

1.1

—

Familial erythrocytosis

3.92

1.72

1.2

—

nmol/l

—

Synovial cyst of popliteal space [Baker]

315

1.47

1.71

1.3

0.34

0.46

nmol/l

—

All dysplastic lesions of the vulva

211

1.58

1.68

1.1

1.3

—

0.38

nmol/l

—

Melanocytic naevi of other and unspecified parts of face

259

1.51

1.68

1.3

1.2

—

0.42

nmol/l

—

Dental caries 3 and operation codes, only avohilmo

240

1021

1.18

1.66

1.3

0.33

0.14

nmol/l

0.88

Disorders of parathyroid gland, other and/or unspecified

2.85

1.66

2.0

1.2

—

nmol/l

—

Bell's palsy

537

1.35

1.65

1.3

0.12

0.34

nmol/l

—

Myopia

573

1.33

1.63

1.3

0.14

0.32

nmol/l

—

Other surgical follow-up care

120

1.76

1.62

1.1

1.3

—

0.49

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

661

1.31

1.61

1.4

1.3

0.14

0.36

nmol/l

—

Maternal care for other conditions predominantly related to pregnancy

131

1046

1.24

1.61

1.2

1.3

0.20

0.21

nmol/l

—

Acute appendicitis, with complications

125

1007

1.24

1.61

1.1

1.3

0.26

nmol/l

—

Osteonecrosis

238

1.52

1.60

1.5

1.3

0.38

0.39

nmol/l

—

Open wound of head

321

2768

1.14

1.59

1.2

1.3

0.26

0.24

nmol/l

0.12

191

Benign neoplasm: Ill-defined sites within the digestive system

2.75

1.59

2.3

1.1

—

nmol/l

—

Benign neoplasm: Ill-defined sites within the digestive system

2.75

1.59

2.3

1.2

—

nmol/l

—

Pedal cyclist injured in transport accident

142

1162

1.23

1.58

1.2

1.3

0.13

0.25

nmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

403

2920

1.13

1.58

1.3

0.17

0.24

nmol/l

1.07

168

Retinal detachments and breaks

219

1867

1.18

1.57

1.3

0.25

0.28

nmol/l

0.14

147

Macular pucker

673

1.30

1.57

1.1

1.3

0.16

0.26

nmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

457

1.36

1.55

1.3

0.12

0.34

nmol/l

—

Dermatophytosis

587

1.32

1.55

1.4

1.3

0.32

0.31

nmol/l

—

Nonsuppurative otitis media

136

959

1.23

1.54

1.4

1.3

0.18

0.33

nmol/l

0.94

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

307

1844

1.15

1.54

1.3

1.2

0.19

0.26

nmol/l

0.52

138

Other and unspecified myoneural disorders

3.42

1.53

1.4

1.2

—

nmol/l

—

Flat foot [pes planus] (acquired)

484

1.35

1.53

1.4

1.3

0.15

0.40

nmol/l

—

Organic, including symptomatic, mental disorders

227

1911

0.86

1.53

1.3

0.30

0.27

nmol/l

0.14

145

Other congenital malformations of tongue, mouth and pharynx

0.00

1.53

0.0

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

133

1086

1.23

1.52

1.3

0.18

0.31

nmol/l

1.28

Nasal polyp

115

925

1.25

1.52

1.3

0.13

0.22

nmol/l

—

Disorder of external ear, unspecified

116

1.74

1.49

1.1

1.3

—

0.45

—

Other and unspecified disorders of psychological development

2.57

1.49

1.1

—

Disorders of eyelid in diseases classified elsewhere

124

1.71

1.47

1.6

1.3

—

0.58

nmol/l

—

Effects of foreign body entering through natural orifice

145

1200

1.21

1.47

1.3

0.34

0.20

nmol/l

0.31

Primary open-angle glaucoma

188

1554

1.18

1.45

1.3

0.18

0.28

nmol/l

0.89

121

Other and unspecified vaccines and biological substances

2.77

1.44

1.0

1.2

—

Intermittent heterotropia

228

1.50

1.44

1.4

1.2

—

0.66

nmol/l

—

Other hammer toe(s) (acquired)

119

907

1.23

1.43

1.3

0.22

0.31

nmol/l

0.64

Seborrhoeic keratosis

142

1177

1.21

1.43

1.3

0.19

0.28

nmol/l

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

387

1.37

1.42

1.4

1.3

0.20

0.38

nmol/l

—

Other spirochaetal diseases

167

1407

1.19

1.41

1.3

0.13

0.26

nmol/l

—

100

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.10

1.39

1.0

1.5

—

0.58

—

LSIL lesion of the vulva

142

1.63

1.39

1.1

1.3

—

0.44

nmol/l

—

Multiple delivery

469

0.68

1.38

1.2

1.3

0.12

0.20

nmol/l

—

Benign neoplasm: Liver/bile ducts

104

1.75

1.37

1.1

1.2

—

0.66

nmol/l

—

Fall on and from stairs and steps

156

1310

1.19

1.37

1.3

0.18

0.23

nmol/l

0.64

Sequelae of injuries of upper limb

469

1.33

1.35

1.5

1.3

0.15

0.34

nmol/l

—

Fracture at wrist and hand level

215

1856

1.16

1.35

1.3

0.13

0.25

nmol/l

2.65

119

Spontaneous abortion

331

1997

1.13

1.34

1.3

1.2

0.29

0.24

nmol/l

0.17

108

Coxarthrosis, primary

386

3004

1.12

1.34

1.3

0.18

0.25

nmol/l

0.92

238

Primary open-angle glaucoma, strict

153

1284

1.19

1.33

1.3

0.19

0.30

nmol/l

0.71

103

Alcohol withdrawal state with delirium

274

1.43

1.33

1.4

1.3

0.14

0.25

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

702

4214

1.09

1.32

1.3

0.23

0.24

nmol/l

0.02

269

Purpura and other haemorrhagic conditions

612

1.28

1.31

1.4

1.3

0.31

0.32

nmol/l

—

Other injuries of lower limb, level unspecified

2.53

1.31

1.3

1.1

—

Other congenital malformations of limb(s)

2.53

1.31

3.7

1.3

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

298

1816

1.13

1.30

1.3

1.2

0.18

0.26

nmol/l

0.67

138

Deficiency of other B group vitamins

1.86

1.30

1.1

1.3

—

0.52

—

Unspecified abortion

257

0.58

1.30

1.1

1.3

—

0.32

nmol/l

—

Other congenital malformations of face and neck

106

1.71

1.30

1.2

1.3

—

0.50

nmol/l

—

Other keratitis

508

1.30

1.29

1.2

1.3

0.16

0.29

nmol/l

—

Ascites

260

1.43

1.27

1.6

1.3

0.18

0.38

nmol/l

—

Melanoma in situ of lower limb, including hip

2.44

1.25

1.7

1.2

—

Second line medication for Crohn's disease

392

3538

1.11

1.25

1.2

1.3

0.26

0.23

nmol/l

0.14

220

Mucosal proctocolitis

599

1.27

1.24

1.2

1.3

0.28

0.32

nmol/l

—

Psoriasis vulgaris

116

960

1.21

1.23

1.3

0.14

0.26

nmol/l

—

Pyogenic arthritis

262

1.42

1.22

1.6

1.3

0.13

0.43

nmol/l

—

Other maternal disorders predominantly related to pregnancy

420

2388

1.11

1.22

1.2

1.3

0.14

0.24

nmol/l

2.02

124

ILD, hospital admission 2, with pulmonary infections

347

1.36

1.22

1.5

1.3

0.15

0.34

nmol/l

—

Complications associated with artificial fertilization

2.06

1.22

2.3

1.1

—

nmol/l

—

Other respiratory diseases principally affecting the interstitium

753

1.24

1.22

1.5

1.3

0.14

0.29

nmol/l

1.81

Inguinal hernia, bilateral

385

0.67

1.21

1.3

0.67

0.22

nmol/l

—

Burns and corrosions

637

1.26

1.21

1.2

1.3

0.13

0.27

nmol/l

—

Rheumatic fever incl heart disease

109

1.66

1.19

1.3

1.2

—

0.70

nmol/l

—

Single delivery by forceps and vacuum extractor

487

0.77

1.19

1.3

—

0.18

nmol/l

—

Other demyelinating diseases of the central nervous system

149

1.55

1.17

1.5

1.3

—

0.53

nmol/l

—

Other vitreous opacities

141

1.57

1.17

1.1

1.2

—

0.29

nmol/l

—

Lymphoid leukaemia

198

1.47

1.17

1.6

1.3

0.16

0.41

nmol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

282

1.39

1.16

1.3

0.14

0.41

nmol/l

—

Inguinal or femoral hernia, bilateral

392

0.69

1.15

1.3

0.67

0.22

nmol/l

—

Lymphoid leukaemia

199

1.46

1.14

1.6

1.3

0.16

0.43

nmol/l

—

Macular cyst

1.70

1.14

1.1

1.3

—

0.59

—

Malignant melanoma

689

1.24

1.12

1.2

1.3

0.22

0.30

nmol/l

0.48

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

396

1.32

1.12

1.5

1.3

0.10

0.35

nmol/l

—

Sulfasalazine

186

1618

1.15

1.12

1.2

1.3

0.26

0.25

nmol/l

—

102

Ulcerative colitis (strict definition, require KELA)

102

844

1.21

1.11

1.2

1.3

0.28

nmol/l

—

Unspecified lump in breast

108

900

1.20

1.10

1.4

1.3

0.38

0.29

nmol/l

—

Cutis laxa senilis

2.22

1.09

1.0

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

128

1.57

1.08

1.3

1.4

—

0.58

nmol/l

—

Premenstrual syndrome

2.21

1.08

1.1

1.2

—

Benign neoplasm: Liver

1.70

1.08

1.1

1.2

—

0.74

nmol/l

—

Other ulcerative colitis

244

1.40

1.07

1.1

1.3

—

0.35

nmol/l

—

L04AX Other immunosuppressants

380

3458

1.10

1.07

1.2

1.3

0.27

0.23

nmol/l

0.18

215

Other disorders of veins

266

2375

1.12

1.07

1.3

0.20

0.19

nmol/l

0.07

153

Benign mammary dysplasia

100

831

1.21

1.06

1.3

0.14

0.31

nmol/l

—

Ulcerative proctitis

245

1.39

1.05

1.2

1.3

—

0.38

nmol/l

—

Malignant neoplasm of breast, HER2-negative

303

2471

0.90

1.05

1.3

1.2

0.17

0.23

nmol/l

1.21

149

Malignant neoplasm of prostate

188

1035

1.15

1.04

1.4

1.3

0.18

0.28

nmol/l

0.64

103

Outcome of delivery

527

0.80

1.04

1.3

—

0.16

nmol/l

—

severe traumatic brain injury, does not include concussion

112

942

1.19

1.04

1.1

1.3

0.16

0.27

nmol/l

—

Malignant melanoma of skin

517

1.26

1.03

1.2

1.3

0.23

0.33

nmol/l

—

Disorders of synovium and tendon in diseases classified elsewhere

1.70

1.02

1.1

1.3

—

0.64

—

Seronegative rheumatoid arthritis

608

1.24

1.02

1.2

1.3

0.12

0.31

nmol/l

—

Alcohol abuse, main dg, excluding more controls

626

1.23

1.01

1.3

0.16

0.26

nmol/l

—

Lyme disease

160

1390

1.15

1.01

1.3

0.13

0.26

nmol/l

—

101

Focal brain injury

205

1.42

1.00

1.0

1.3

—

0.33

nmol/l

—

Lung diseases due to external agents

538

1.25

0.99

1.5

1.3

0.18

0.31

nmol/l

—

Carcinoma in situ of breast

2.21

0.98

1.4

1.2

—

nmol/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

683

1.22

0.98

1.2

1.3

0.14

0.32

nmol/l

—

Amputation

344

1.31

0.97

1.2

1.3

0.12

0.29

nmol/l

—

Microscopic polyangiitis

0.00

0.97

0.0

1.2

—

Malignant neoplasm of skin

393

2709

1.09

0.97

1.3

0.20

0.26

nmol/l

0.49

214

Malignant neoplasm of breast

314

2497

0.91

0.97

1.3

1.2

0.17

0.23

nmol/l

1.17

151

Corns and callosities

310

1.33

0.96

1.2

1.3

—

0.45

—

Superficial injury of hip and thigh

612

1.23

0.96

1.3

0.24

0.34

nmol/l

—

Unspecified misadventure during surgical and medical care

225

1.38

0.94

1.7

1.3

0.24

0.43

nmol/l

—

Superficial injury of thorax

696

1.21

0.94

1.2

1.3

0.16

0.30

nmol/l

—

Other and unspecified nonscarring hair loss

2.25

0.94

1.3

1.2

—

malignant neoplasm of male genital organs

194

1087

1.13

0.93

1.4

1.3

0.18

0.27

nmol/l

0.60

108

Benign neoplasm: Skin of other and unspecified parts of face

498

1.25

0.93

1.3

0.12

0.36

nmol/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

243

1.36

0.93

1.2

—

0.36

nmol/l

—

Open wound of wrist and hand

267

2387

1.11

0.92

1.3

0.24

0.27

nmol/l

—

150

Erythema nodosum

134

1.50

0.92

1.4

1.3

—

0.25

nmol/l

—

Endometriosis of fallopian tube

2.17

0.92

1.2

—

Recurrent and persistent haematuria

2.17

0.92

1.0

1.2

—

nmol/l

—

Other congenital malformations of female genitalia

2.16

0.92

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

133

1151

1.16

0.91

1.3

0.18

0.28

nmol/l

0.98

Pterygium

1.60

0.91

1.3

—

0.51

nmol/l

—

Melanoma in situ of lower limb, including hip

2.10

0.90

1.7

1.1

—

Drug-induced systemic lupus erythematosus

2.10

0.90

1.3

1.2

—

Alcoholic liver disease

394

1.27

0.89

1.5

1.3

0.14

0.29

nmol/l

1.12

Benign neoplasm: Skin of upper limb, including shoulder

1.66

0.88

1.6

1.3

—

0.94

nmol/l

—

Alzheimer’s disease (Early onset)

128

0.55

0.88

1.3

1.2

—

0.15

—

Fracture of forearm

377

3249

1.09

0.88

1.3

0.18

0.21

nmol/l

0.57

200

ILD, hospital admissions

620

1.21

0.88

1.5

1.3

0.15

0.31

nmol/l

—

Leiomyosarcoma

2.03

0.87

1.2

—

Varicose veins

433

3027

1.08

0.87

1.2

1.3

0.27

0.25

nmol/l

0.15

205

Type 1 diabetes, strict definition, subgroup 1

315

1.30

0.87

1.1

1.2

—

0.50

nmol/l

—

Lichen planus, including avohilmo

115

989

1.17

0.87

1.3

0.21

0.28

nmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

108

925

1.17

0.86

1.2

1.3

0.28

0.27

nmol/l

—

Dental caries 2 and operation codes, only avohilmo

456

3049

0.93

0.85

1.2

1.3

0.18

0.20

nmol/l

0.30

168

Other diseases of biliary tract

370

1.27

0.85

1.3

0.14

0.36

nmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

103

880

1.17

0.85

1.3

0.13

0.31

nmol/l

—

Other interstitial pulmonary diseases

623

1.21

0.84

1.5

1.3

0.15

0.31

nmol/l

—

Interstitial lung disease

623

1.21

0.84

1.5

1.3

0.15

0.31

nmol/l

—

Interstitial lung disease endpoints

623

1.21

0.84

1.5

1.3

0.15

0.31

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

1.77

0.84

1.5

1.3

—

0.66

—

Inguinal hernia

370

2298

1.09

0.83

1.4

1.3

0.41

0.26

nmol/l

0.45

167

Palmar fascial fibromatosis [Dupuytren]

625

1.20

0.82

1.2

1.3

0.17

0.35

nmol/l

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

1.89

0.82

1.5

1.3

—

nmol/l

—

Dental caries 1 and operation codes, only avohilmo

198

887

1.12

0.82

1.3

0.33

0.14

nmol/l

0.72

Cytomegaloviral disease

1.61

0.81

1.2

1.3

—

0.52

—

Squamous cell neoplasms and carcinomas of the skin

427

1.24

0.80

1.4

1.3

0.20

0.33

nmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

1.68

0.79

1.2

1.3

—

0.58

nmol/l

—

Other bursitis of hip

1.63

0.78

1.1

1.3

—

0.66

—

Recurrent dislocation of patella

200

1.35

0.76

1.1

1.3

—

0.56

nmol/l

—

Benign neoplasm: Bronchus and lung

1.68

0.75

1.0

1.3

—

0.68

nmol/l

—

Basal cell carcinoma, including avohilmo

349

2543

1.08

0.74

1.3

0.19

0.26

nmol/l

0.69

204

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

122

896

1.14

0.74

1.2

0.14

0.30

nmol/l

1.68

Other and unspecified injuries of wrist and hand

150

1.41

0.73

1.2

1.3

—

0.52

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

106

768

1.15

0.72

1.2

1.3

0.14

0.33

nmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.56

0.72

1.6

1.3

—

0.57

nmol/l

—

Carcinoma in situ of breast

1.95

0.71

1.4

1.2

—

nmol/l

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

109

1.48

0.71

1.1

1.2

—

0.64

nmol/l

—

Unspecified parasitic disease

1.94

0.71

1.0

1.2

—

Urticaria due to cold and heat

1.94

0.71

1.0

1.2

—

Pregnancy, childbirth and the puerperium

197

929

1.11

0.71

1.2

1.3

0.41

0.25

nmol/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

180

1619

0.90

0.70

1.4

1.2

0.19

0.25

nmol/l

—

Type 1 diabetes, strict definition

336

1.25

0.69

1.1

1.2

—

0.50

nmol/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.68

0.69

1.0

1.5

—

0.48

—

1.57

0.68

1.3

—

0.68

—

Hypermetropia

275

1.28

0.68

1.2

1.3

—

0.41

nmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

302

1.26

0.67

1.0

1.3

—

0.37

nmol/l

—

Keratoconus

0.54

0.67

1.0

1.4

—

0.50

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

329

2411

1.08

0.67

1.3

0.19

0.26

nmol/l

0.60

192

Malignant neoplasm of parotid gland

1.80

0.66

2.4

1.2

—

nmol/l

—

Acute and transient psychotic disorders

595

1.18

0.66

1.2

1.3

0.16

0.29

nmol/l

—

Valvular operations

558

1.18

0.66

1.6

1.3

0.14

0.46

nmol/l

—

Reactive arthropathies, FINNGEN

313

1.25

0.65

1.2

1.3

—

0.47

nmol/l

—

ILD, hospital admissions 1, main diag only

560

1.18

0.64

1.6

1.3

0.14

0.33

nmol/l

—

Carcinoma in situ of vulva

1.74

0.64

1.2

—

Basal cell carcinoma

336

2493

1.07

0.64

1.3

0.18

0.27

nmol/l

0.78

199

Maternal care for known or suspected fetal abnormality and damage

661

0.85

0.64

1.6

1.2

—

0.20

nmol/l

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

152

1314

1.11

0.63

1.2

0.15

0.25

nmol/l

1.58

Injury of muscle and tendon at lower leg level

710

1.16

0.62

1.2

1.3

0.10

0.26

nmol/l

—

Bicuspidal aortic valve syndrome

138

1.38

0.62

1.1

1.4

—

0.35

nmol/l

—

Embolic stroke

138

1.38

0.62

1.4

1.2

—

0.14

nmol/l

—

Complications of labour and delivery

416

2470

0.94

0.62

1.2

1.3

0.16

0.24

nmol/l

1.28

134

Seropositive rheumatoid arthritis

155

1396

1.11

0.62

1.2

1.3

0.22

0.24

nmol/l

—

109

Chronic ulcer of skin, not elsewhere classified

271

1.26

0.61

1.5

1.3

0.14

0.43

nmol/l

—

Respiratory disorders in diseases classified elsewhere

1.58

0.60

1.4

1.1

—

Use of entacapone

0.00

0.60

0.0

1.2

—

Postpartum haemorrhage due to anatomy

423

0.80

0.60

1.8

1.2

—

0.13

nmol/l

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.60

0.0

1.0

—

Mandibular hypoplasia

0.00

0.60

0.0

1.1

—

Use of selegiline

157

1.34

0.59

1.5

1.3

0.98

0.40

nmol/l

1.44

Ovarian hyperstimulation (induction)

1.57

0.59

2.3

1.2

—

nmol/l

—

Follicular lymphoma, hilmo

166

1.33

0.58

1.1

1.3

—

0.44

nmol/l

—

Parkinson's disease

631

1.16

0.58

1.5

1.3

0.75

0.22

nmol/l

3.47

Androgenic alopecia

1.73

0.58

1.2

1.1

—

nmol/l

—

Colorectal cancer

121

1083

1.12

0.58

1.3

0.23

0.30

nmol/l

—

Uterine polyps

511

1.18

0.57

1.1

1.2

—

0.25

nmol/l

—

Contraceptive management

242

1838

0.92

0.57

1.3

0.16

0.23

nmol/l

0.49

118

Chorioretinal inflammation

115

1.40

0.56

1.1

1.3

—

0.52

nmol/l

—

Convergent concomitant strabismus

247

1.26

0.56

1.4

1.3

—

0.45

nmol/l

—

Dermatopolymyositis (FG)

1.46

0.56

1.0

1.3

—

0.87

nmol/l

—

Other specific arthropathies, wide

1.47

0.54

1.3

—

0.74

nmol/l

—

Retinal detachment with retinal break

580

1.16

0.54

1.5

1.3

0.19

0.27

nmol/l

—

Other/unspecified reactive arthropathies

276

1.23

0.54

1.1

1.3

—

0.38

nmol/l

—

Benign neoplasm: Conjunctiva

125

1.37

0.53

1.0

1.3

—

0.63

nmol/l

—

Benign neoplasm of major salivary glands

432

1.18

0.53

1.2

1.3

0.10

0.36

nmol/l

—

Systemic sclerosis,strict definition

1.55

0.53

1.5

1.2

—

Other nonscarring hair loss

1.55

0.53

1.3

1.2

—

Benign neoplasm: Conjunctiva

126

1.35

0.51

1.0

1.3

—

0.59

nmol/l

—

Hereditary corneal dystrophies

136

0.66

0.51

1.1

1.2

—

0.60

nmol/l

—

Maternal care for other known or suspected fetal problems

134

778

1.11

0.51

1.3

—

0.19

nmol/l

—

Crossbite

241

1.23

0.50

1.2

1.3

—

0.35

nmol/l

—

All dysplastic lesions of the vagina

118

1.36

0.50

1.1

1.3

—

0.50

—

Benign neoplasm: Skin of trunk

171

1.29

0.50

1.4

1.3

—

0.47

nmol/l

—

Mixed disorders of conduct and emotions, excluding more controls

1.50

0.49

1.0

1.1

—

Other (seronegative) rheumatoid arthritis, wide

111

1001

1.11

0.49

1.2

1.3

0.18

0.27

nmol/l

0.73

Parkinson's disease, including avohilmo

662

1.13

0.48

1.4

1.3

0.75

0.21

nmol/l

3.63

Migraine without aura, drug-induced

1.50

0.47

1.6

1.2

—

Postpartum care and examination

433

1.14

0.47

1.2

1.3

—

0.19

nmol/l

—

Fracture of shoulder and upper arm

212

1973

1.07

0.47

1.3

0.16

0.24

nmol/l

1.34

127

Benign neoplasm: Skin of trunk

173

1.28

0.46

1.4

1.3

—

0.44

nmol/l

—

Amblyopia ex anopsia

138

1.31

0.45

1.3

1.2

—

0.51

nmol/l

—

Diabetic neuropathy

588

1.14

0.44

1.2

1.4

0.10

0.17

nmol/l

—

Diabetic retinopathy, strict definition

119

954

1.10

0.43

1.3

1.4

0.22

0.17

nmol/l

—

Persons encountering health services in circumstances related to reproduction

392

2528

1.05

0.43

1.6

1.3

0.17

0.22

nmol/l

0.62

159

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

162

0.74

0.42

1.4

1.3

—

0.53

—

1.57

0.42

1.0

1.1

—

Drug-induced obesity

1.57

0.42

1.0

1.2

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.55

0.42

1.0

1.2

—

Disorders of tooth development and eruption

180

1.25

0.42

1.1

1.2

—

0.18

nmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

632

1.12

0.42

1.4

1.3

0.15

0.27

nmol/l

1.21

Retinal breaks without detachment

838

0.89

0.41

1.3

0.44

0.25

nmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

295

1.19

0.41

1.2

1.3

—

0.40

nmol/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.41

0.0

1.1

—

Other and unspecified localized connective tissue disorders

0.00

0.41

0.0

1.3

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

0.41

0.0

1.3

—

Malignant neoplasm of gum

0.00

0.41

0.0

1.2

—

Adenocarcinomas of cervix

0.00

0.41

0.0

1.2

—

Primary coxarthrosis, bilateral

162

1504

1.08

0.41

1.3

0.21

0.29

nmol/l

0.47

114

Hypoplasia of dental enamel, including avohilmo

0.00

0.41

0.0

1.2

—

Parkinson's disease, strict definition

576

1.13

0.41

1.4

1.3

0.83

0.22

nmol/l

3.71

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

1.36

0.41

1.3

1.5

—

0.54

—

Thalassaemia

0.00

0.41

0.0

1.2

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.41

0.0

1.2

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.41

0.0

1.2

—

Type1 diabetes, definitions combined, early onset

276

1.19

0.41

1.6

1.3

—

0.46

nmol/l

—

ILD, hospital admissions 3, with pneumonia sepsis

296

1.18

0.40

1.7

1.3

0.13

0.43

nmol/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

159

1.26

0.40

1.3

1.2

—

0.50

nmol/l

—

Alzheimer’s disease (undefined)

0.00

0.40

0.0

1.2

—

Benign neoplasm: Other/unspecified site

1.32

0.39

1.3

1.4

—

0.58

nmol/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

1.43

0.39

1.0

1.1

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.3

—

Burn and corrosion, body region unspecified

0.00

0.39

0.0

1.2

—

Use of levodopa decarboxylase inhibitor

541

1.13

0.39

1.4

1.3

0.83

0.25

nmol/l

3.35

Open bite

187

1.23

0.39

2.0

1.3

—

0.62

nmol/l

—

Gestational diabetes (for exclusion)

212

1409

1.07

0.38

1.2

1.3

0.18

0.19

nmol/l

—

Degeneration of nervous system due to alcohol

1.37

0.38

1.2

1.3

—

0.44

—

Degeneration of the brain due to alcohol

1.37

0.38

1.2

1.3

—

0.44

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

129

1192

1.08

0.38

1.4

1.3

0.21

0.27

nmol/l

—

Motor disorders, excluding more controls

1.37

0.37

1.4

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

505

1.13

0.37

1.2

1.3

0.16

0.31

nmol/l

—

Follicular lymphoma

179

1.23

0.37

1.1

1.3

—

0.46

nmol/l

—

Oral lichen ruber planus

114

0.70

0.37

1.1

1.3

—

0.61

nmol/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

170

1.24

0.37

1.3

1.4

—

0.37

nmol/l

—

Rheumatic valve diseases

1.29

0.36

1.2

1.3

—

0.82

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

271

1681

0.95

0.36

1.2

1.3

0.26

0.25

nmol/l

0.05

Other diseases of appendix

1.43

0.35

1.0

1.2

—

Divergent concomitant strabismus

342

0.85

0.35

1.1

1.3

—

0.38

nmol/l

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

1.32

0.35

1.6

1.2

—

0.61

nmol/l

—

Burns and corrosions of external body surface, specified by site

490

1.12

0.34

1.2

1.3

0.13

0.30

nmol/l

—

Erythema multiforme

1.32

0.34

1.2

1.4

—

0.60

—

Open wound of lower leg

673

1.10

0.32

1.4

1.3

0.22

0.31

nmol/l

—

Mixed disorders of conduct and emotions

1.35

0.32

1.0

1.2

—

Bacterial pneumonia (organism specified)

225

2157

0.95

0.32

1.3

0.23

0.29

nmol/l

0.38

153

Injury of muscle and tendon at wrist and hand level

674

1.10

0.32

1.4

1.3

0.18

0.28

nmol/l

—

Filling of root of tooth

128

1.25

0.32

1.0

1.3

—

0.61

—

Congenital malformations of aortic and mitral valves

156

1.22

0.31

1.1

1.3

—

0.35

nmol/l

—

Alzheimer’s disease (Early onset), excluding more controls

0.69

0.30

1.3

1.1

—

0.17

—

Optic neuritis

175

1.20

0.30

1.1

1.3

—

0.50

nmol/l

—

Other disorders of iris and ciliary body

1.29

0.30

1.1

1.2

—

0.68

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

152

0.79

0.29

1.4

1.3

—

0.46

—

Dermatitis due to ingested food

105

0.73

0.29

1.0

1.2

—

nmol/l

—

Benign neoplasm: Short bones of upper limb

1.23

0.29

1.0

1.4

—

0.86

—

Polycystic ovarian syndrome, broad definition

430

1.12

0.29

1.1

—

0.16

nmol/l

—

Left hemicolectomy

1.30

0.28

1.5

1.3

—

0.70

—

Malignant neoplasm of ovary

248

0.84

0.28

1.1

1.2

—

0.41

nmol/l

—

Status post-ami

150

0.82

0.27

1.1

1.2

—

0.37

—

Malignant neoplasm of bronchus and lung

665

1.08

0.26

1.2

1.3

0.16

0.30

nmol/l

—

Open wound of abdomen, lower back and pelvis

104

1.25

0.26

1.2

1.4

—

0.46

—

Acute nephritic syndrome

1.30

0.26

1.3

1.4

—

0.41

—

Left ventricular outflow tract obstruction, narrow definition

178

1.18

0.26

1.0

1.4

—

0.34

nmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

320

2423

1.04

0.26

1.2

1.3

0.13

0.24

nmol/l

1.96

123

Otosclerosis

386

1.12

0.26

1.5

1.3

0.47

0.40

nmol/l

—

Coronary angioplasty

194

1421

1.05

0.25

1.3

0.17

0.31

nmol/l

1.15

114

Desensitization to allergens

207

1.16

0.25

1.3

—

0.44

nmol/l

—

Beningn neoplasm: Meninges, unspecified

1.20

0.25

1.1

1.3

—

0.80

—

Emergency coronary revascularization (for ACS)

280

2088

0.96

0.24

1.3

0.16

0.27

nmol/l

1.59

166

Contact with sharp object, undetermined intent

1.29

0.24

1.2

1.4

—

0.50

—

Schizophrenia

828

0.93

0.24

1.3

0.16

0.24

nmol/l

0.69

Vertical strabismus

124

1.21

0.24

1.1

1.3

—

0.52

nmol/l

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

152

1.19

0.24

1.2

—

0.40

nmol/l

—

Foreign body in genitourinary tract

1.32

0.23

1.0

1.1

—

Monoarthritis, not elsewhere classified

171

1.17

0.23

1.2

1.4

—

0.58

nmol/l

—

Benign neoplasm of major salivary glands

467

1.09

0.22

1.2

1.3

0.10

0.37

nmol/l

—

Glucosamine medication

315

2432

1.03

0.22

1.2

1.3

0.21

0.27

nmol/l

0.46

178

Use of ropinirole

144

1.18

0.22

1.5

1.3

0.94

0.38

nmol/l

—

Mandibular retrognathia

283

0.88

0.22

1.1

1.3

—

0.41

nmol/l

—

Failure in dosage during surgical and medical care

0.00

0.21

0.0

1.3

—

Traumatic amputation of hip and thigh

0.00

0.21

0.0

1.2

—

Other inherited muscular atrophy

0.00

0.21

0.0

1.5

—

Disorders of glossopharyngeal nerve

0.00

0.21

0.0

1.1

—

Haemophilus septicemia

0.00

0.21

0.0

1.2

—

Telogen effluvium

0.00

0.21

0.0

1.3

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

0.21

0.0

1.1

—

Malignant neoplasm of accessory sinuses

0.00

0.21

0.0

1.2

—

Pemphigus vulgaris

0.00

0.21

0.0

1.4

—

Traumatic amputation of ankle and foot

0.00

0.21

0.0

1.1

—

Reduction defects of upper limb

0.00

0.21

0.0

1.2

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.21

0.0

1.1

—

Other and unspecified heterotropia

0.00

0.21

0.0

1.2

—

Bradycardia, unspecified, drug-induced

0.00

0.21

0.0

1.3

—

Congenital malformations of great veins

0.00

0.21

0.0

1.5

—

Acanthosis nigricans

0.00

0.21

0.0

1.3

—

Injury of blood vessels of thorax

0.00

0.21

0.0

1.2

—

Malignant neoplasm of anus and anal canal

0.00

0.21

0.0

1.4

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.21

0.0

1.3

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.4

—

Labyrinthine fistula

0.00

0.21

0.0

1.2

—

Erectile dysfunction, exclusion

0.00

0.21

0.0

1.1

—

Unspecified organic or symptomatic mental disorder

0.00

0.21

0.0

1.3

—

Complications of anaesthesia during labour and delivery

0.00

0.21

0.0

1.2

—

Acute thyroiditis

0.00

0.21

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of elbow

277

1.12

0.21

1.2

1.3

—

0.41

nmol/l

—

Acute alcohol intoxication

129

1227

1.05

0.21

1.2

1.3

0.18

0.29

nmol/l

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.21

0.0

1.2

—

Motor disorders

1.16

0.21

1.4

1.1

—

Use of riluzole

0.00

0.21

0.0

1.1

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.20

0.0

1.2

—

Lichenoid drug reaction

0.00

0.20

0.0

1.4

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.20

0.0

1.3

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

0.20

0.0

1.2

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.20

0.0

1.3

—

Molar incisor enamel hypoplasia, with caries

0.00

0.20

0.0

1.2

—

Alcohol abuse, main dg

722

1.07

0.20

1.3

0.16

0.24

nmol/l

—

Prolapse and hernia of ovary and fallopian tube

164

0.84

0.20

1.2

—

0.27

—

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

113

0.79

0.20

1.1

1.2

—

0.40

nmol/l

—

1.23

0.20

1.8

1.2

—

Acute alcohol intoxication, ICD10

100

947

1.06

0.19

1.2

1.3

0.19

0.24

nmol/l

—

Pemphigoid

1.22

0.19

1.3

1.2

—

0.70

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.16

0.19

1.2

1.5

—

0.71

nmol/l

—

Erectile dysfunction

261

1.11

0.18

1.2

1.4

0.30

0.23

nmol/l

—

Other disorders of breast and lactation associated with childbirth

1.21

0.18

1.0

1.1

—

nmol/l

—

Delivery, wide proxy

223

1146

1.04

0.18

1.2

1.3

0.31

0.23

nmol/l

0.24

Coronary revascularization (ANGIO or CABG)

253

1710

1.03

0.18

1.3

0.16

0.28

nmol/l

1.21

130

Delivery

281

1442

1.03

0.18

1.2

1.3

0.38

0.22

nmol/l

0.57

Schizophrenia or delusion

186

1796

1.04

0.17

1.3

0.24

nmol/l

0.02

105

Assault by sharp object

0.74

0.17

1.0

1.5

—

0.58

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

205

1.12

0.17

1.1

1.3

—

0.41

nmol/l

—

Unspecified acute lower respiratory infection

650

1.06

0.17

1.4

1.3

0.19

0.27

nmol/l

—

Antenatal screening

120

706

0.96

0.16

1.2

1.3

0.42

0.16

nmol/l

—

Coxarthrosis, primary, with hip surgery

272

2509

1.03

0.16

1.3

0.20

0.27

nmol/l

0.52

189

Malignant neoplasm of respiratory system and intrathoracic organs

788

1.05

0.16

1.2

1.3

0.15

0.28

nmol/l

—

Bacterial pneumonia, not elsewhere classified

198

1808

0.97

0.16

1.3

0.27

0.30

nmol/l

0.14

122

Struck by thrown, projected or falling objec

178

1.12

0.15

1.1

1.4

—

0.30

nmol/l

—

Carcinoma in situ of cervix uteri

381

1.08

0.14

1.2

1.1

—

0.42

nmol/l

—

Malignant neoplasm of breast, HER-negative

125

1297

0.96

0.14

1.2

1.3

0.15

0.26

nmol/l

1.70

Benign neoplasm: salivary glands, exclude unknown (D119)

411

1.07

0.14

1.2

1.3

0.10

0.41

nmol/l

—

Schizophrenia, schizotypal and delusional disorders

186

1806

1.03

0.14

1.3

0.24

0.23

nmol/l

0.06

103

Rheumatoid arthritis, including avohilmo

237

2313

1.02

0.13

1.2

1.3

0.18

0.22

nmol/l

0.51

156

Dental caries 2 and operation codes

511

3995

1.02

0.12

1.3

0.17

0.22

nmol/l

0.91

233

Bacterial pneumoniae

212

1924

0.98

0.12

1.3

0.25

0.29

nmol/l

0.21

129

Non-small cell lung cancer, squamous

127

0.87

0.12

1.0

1.2

—

0.51

nmol/l

—

Non-small cell lung cancer, squamous, helper endpoint

127

0.87

0.12

1.0

1.2

—

0.51

nmol/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

210

1.10

0.12

1.1

1.2

—

0.40

nmol/l

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

294

1884

1.02

0.11

1.3

1.2

0.17

0.26

nmol/l

1.38

109

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

294

1884

1.02

0.11

1.3

1.2

0.17

0.26

nmol/l

1.38

109

Coronary artery bypass grafting

113

887

0.97

0.10

1.2

1.3

0.13

0.35

nmol/l

2.01

Diffuse brain injury

1.15

0.10

1.1

1.4

—

0.53

nmol/l

—

Diabetic retinopathy

230

1422

1.02

0.10

1.3

1.4

0.22

nmol/l

0.01

125

Antepartum haemorrhage, not elsewhere classified

392

0.94

0.10

1.1

1.2

—

0.13

nmol/l

—

Short stature, not elsewhere classified

1.14

0.10

1.2

—

nmol/l

—

Specific developmental disorder of motor function

1.12

0.10

1.4

1.1

—

Carcinoma in situ of cervix uteri, endocervix

1.09

0.09

1.2

—

nmol/l

—

Carcinoma in situ of cervix uteri, endocervix

1.06

0.09

1.2

—

nmol/l

—

Benign neoplasm: Skin of ear and external auricular canal

145

0.90

0.09

1.3

1.2

—

0.50

—

Agranulocytosis

553

0.96

0.09

1.6

1.3

0.15

0.34

nmol/l

—

Motorcycle rider injured in noncollision transport accidents

107

1.12

0.08

1.2

1.3

—

0.50

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.83

0.08

1.0

1.2

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

0.79

0.08

1.2

1.3

—

0.37

—

Other embolism and thrombosis

627

1.04

0.08

1.3

0.18

0.25

nmol/l

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.06

0.08

1.1

1.3

—

0.68

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

358

0.95

0.08

1.2

1.3

—

0.33

nmol/l

—

Other obstetric trauma

215

0.93

0.07

1.1

1.2

—

0.16

—

Fracture of femur

120

1070

1.02

0.07

1.3

0.14

0.28

nmol/l

2.70

Viral pneumonia (known virus, not influenza)

0.81

0.07

1.5

1.3

—

0.54

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

0.80

0.07

1.2

—

0.70

nmol/l

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

1.08

0.07

1.1

1.4

—

0.64

nmol/l

—

Exposure to smoke, fire and flames

0.82

0.07

1.0

1.3

—

0.58

—

Erythema intertrigo

0.84

0.06

1.3

—

0.48

nmol/l

—

Drug-induced cataract

0.84

0.06

1.8

1.2

—

0.62

—

Syphilis

102

0.88

0.06

1.2

1.4

—

0.50

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

182

0.93

0.05

1.1

1.2

—

0.49

nmol/l

—

Dental caries 2

517

4030

1.01

0.05

1.3

0.17

0.23

nmol/l

0.96

237

Benign neoplasm: Skin of ear and external auricular canal

141

0.92

0.05

1.3

1.2

—

0.64

—

Injuries to the hip and thigh

253

2290

1.01

0.05

1.3

0.18

0.28

nmol/l

0.85

164

Other degenerative diseases of the nervous system

121

903

1.02

0.04

1.2

1.3

0.17

0.19

nmol/l

—

Cyst of Bartholin Gland

180

1.06

0.04

1.3

1.2

—

0.36

nmol/l

—

Other and unspecified nonorganic psychotic disorders

101

994

1.02

0.04

1.2

1.3

0.17

0.25

nmol/l

0.71

Mandibular retrognathia AND surgery (BSSRO)

111

1.08

0.04

1.2

1.4

—

0.49

—

Carcinoma in situ of cervix uteri

398

1.03

0.04

1.2

—

0.45

nmol/l

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

119

0.92

0.04

1.0

1.3

—

0.47

nmol/l

—

Serous carcinoma of ovary

179

0.95

0.03

1.1

1.3

—

0.64

nmol/l

—

Carcinoma in situ of other and unspecified genital organs

1.09

0.03

1.2

—

0.50

—

Memory loss

400

1.03

0.02

1.3

0.14

0.35

nmol/l

—

Contact with other sharp object(s)

261

1.03

0.02

1.5

1.3

—

0.32

—

Inflammatory disorders of breast

299

0.97

0.02

1.1

1.2

—

0.45

nmol/l

—

Bacterial meningitis

152

1.05

0.02

1.3

—

0.42

—

Other/unspecified seropositive rheumatoid arthritis

153

1542

0.99

0.02

1.2

1.3

0.22

0.24

nmol/l

—

105

Other/unspecified rheumatoid arthritis

619

0.99

0.02

1.2

1.3

0.23

0.33

nmol/l

—

Embedded and impacted teeth

122

1028

1.01

0.01

1.5

1.3

0.14

0.29

nmol/l

—

Single spontaneous delivery

272

1442

1.00

0.01

1.2

1.3

0.38

0.22

nmol/l

0.57

Varicella [chickenpox]

176

0.97

0.00

1.2

1.3

—

0.31

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

152

1526

1.00

0.00

1.2

1.3

0.22

0.25

nmol/l

—

104

Seropositive rheumatoid arthritis, wide

155

1555

1.00

0.00

1.2

1.3

0.22

0.24

nmol/l

—

105

Major anomalies of jaw size

102

0.98

0.00

1.1

1.3

—

0.55

—

Juvenile osteochondrosis

121

0.99

0.00

1.2

1.3

—

0.58

—

Other and unspecified corneal deformities and disorders

129

1.01

0.00

1.1

1.3

—

0.58

—

Dental caries 2, only avohilmo

503

3967

1.00

0.00

1.2

1.3

0.18

0.22

nmol/l

0.66

233

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.01

0.00

1.2

—

0.70

—

Procedures for purposes other than remedying health state

119

1.01

0.00

1.4

1.3

—

0.63

nmol/l

—

Oesophageal varices

143

0.98

0.00

1.1

1.3

0.18

0.39

nmol/l

—

L02BB Anti-androgens

247

1.01

0.00

2.0

1.3

0.28

0.18

nmol/l

—

Feeding problems of newborn

0.00

0.0

1.1

—

Lichen nitidus

0.00

0.0

1.6

—

Other congenital malformations of integument

0.00

0.0

1.5

—

Drug-induced aplastic anaemia

0.00

0.0

1.2

—

Fibrosis and sclerosis of liver

0.00

0.0

1.1

—

Fat embolism (traumatic)

0.00

0.0

1.0

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.0

1.2

—

Myiasis

0.00

0.0

1.2

—

Edwards' syndrome and Patau's syndrome

0.00

0.0

1.2

—

Burn and corrosion of respiratory tract

0.00

0.0

1.2

—

Perioral dermatitis, drug-induced

0.00

0.0

1.2

—

Rapidly progressive nephritic syndrome

0.00

0.0

1.3

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.0

—

Carcinoma in situ of stomach

0.00

0.0

1.5

—

Use of pergolide

0.00

0.0

1.3

—

Benign neoplasm: Ureter

0.00

0.0

1.3

—

Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

0.0

1.2

—

Nightmares

0.00

0.0

1.3

—

Colorectal squamous cell carcinoma

0.00

0.0

1.3

—

Melanoma in situ of eyelid, including canthus

0.00

0.0

1.2

—

Carcinoma in situ of skin of lip

0.00

0.0

1.3

—

Benign neoplasm: Urethra

0.00

0.0

1.2

—

Hirsutism, drug-induced

0.00

0.0

1.1

—

Brain mixed glioma

0.00

0.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.0

1.2

—

Filariasis

0.00

0.0

1.3

—

Erysipeloid

0.00

0.0

1.3

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.0

1.2

—

Forearm

0.00

0.0

1.1

—

Dementia in other diseases classified elsewhere

160

1.00

0.00

1.3

1.2

0.33

0.58

nmol/l

—

Schistosomiasis [bilharziasis]

0.00

0.0

1.2

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

0.0

1.4

—

Tuberculosis of nervous system

0.00

0.0

1.4

—

Merkel cell carcinoma of skin

0.00

0.0

1.2

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.0

1.2

—

Progressive external ophthalmoplegia

0.00

0.0

1.2

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.7

—

Syndactyly

0.00

0.0

1.0

—

Benign neoplasm: Urethra

0.00

0.0

1.1

—

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

0.00

0.0

1.6

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.0

1.3

—

Alpha thalassaemia

0.00

0.0

1.0

—

Cytomegaloviral pneumonitis

0.00

0.0

1.3

—

Osteogenesis imperfecta

0.00

0.0

1.3

—

Carcinoma in situ of skin of lip

0.00

0.0

1.4

—

Squamous cell neoplasms and carcinoma of rectum

0.00

0.0

1.3

—

Polydactyly

0.00

0.0

1.0

—

Other degenerative disorders of globe

0.00

0.0

1.6

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.0

—

Spina bifida

0.00

0.0

1.1

—

Congenital malformation of optic disc

0.00

0.0

1.7

—

Malignant neoplasm of oropharyng

0.00

0.0

1.3

—

Disorders of glycoprotein metabolism

0.00

0.0

1.2

—

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

0.0

1.4

—

Use of trihexyphenidyl

0.00

0.0

1.3

—

Traumatic secondary and recurrent haemorrhage

0.00

0.0

1.1

—

Carcinoma in situ of larynx

0.00

0.0

1.4

—

Other histiocytosis syndromes

0.00

0.0

1.2

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.0

1.7

—

Linear scleroderma

0.00

0.0

1.7

—

Febrile neutrophilic dermatosis [Sweet]

0.00

0.0

1.5

—

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

0.0

1.6

—

Burns and corrosions of multiple and unspecified body regions

0.91

0.00

1.0

1.4

—

0.58

nmol/l

—

Disorders of copper metabolism

0.00

0.0

1.8

—

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

1.6

—

Benign neoplasm: Ureter

0.00

0.0

1.2

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

0.0

1.2

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

0.0

1.3

—

Crushing injury of head

0.00

0.0

1.2

—

Dislocations, sprains and strains involving multiple body regions

0.00

0.0

1.2

—

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.5

—

Squamous cell neoplasms and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Lichen striatus

0.00

0.0

1.2

—

0.00

0.0

1.5

—

Use of apomorphine

0.00

0.0

1.2

—

Intentional self-harm by drowning and submersion

0.00

0.0

1.6

—

Alcoholic myopathy

0.00

0.0

1.2

—

Merkel cell carcinoma of skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Craniosynostosis EXCLUDE syndromes

0.00

0.0

1.6

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.0

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.3

—

Choroidal detachment

0.00

0.0

1.1

—

Sequelae of malnutrition and other nutritional deficiencies

0.00

0.0

1.1

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

0.0

1.6

—

Severe mental retardation

0.00

0.0

1.7

—

Toxic effect of pesticides

0.00

0.0

1.2

—

Malignant neoplasm of vagina

0.00

0.0

1.2

—

Disorders of olfactory nerve

0.00

0.0

1.2

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

0.0

1.3

—

Pneumoconiosis due to other inorganic dusts

0.00

0.0

1.1

—

Disorders of optic chiasm

0.00

0.0

1.2

—

Hypoplasia of dental enamel, prenatal

0.00

0.0

1.4

—

Need for immunization against certain single viral diseases

0.00

0.0

1.2

—

Other conditions related to polyarteritis nodosa

0.00

0.0

1.2

—

Hereditary choroidal dystrophy

0.00

0.0

1.3

—

Flexion deformity

0.00

0.0

1.0

—

Macular pucker, drug-induced

0.00

0.0

1.3

—

Accident to watercraft causing drowning and submersion

0.00

0.0

1.4

—

Intentional self-harm by smoke, fire and flames

0.00

0.0

1.1

—

Pemphigus erythematosus

0.00

0.0

1.4

—

Acrodermatitis continua

0.00

0.0

1.2

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.2

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

0.0

1.4

—

Sweet's syndrome

0.00

0.0

1.5

—

Drug-induced interstitial lung disorders, unspecified

0.00

0.0

1.3

—

Congenital lactase deficiency

0.00

0.0

1.2

—

Onychogryphosis

0.00

0.0

1.3

—

Mechanical strabismus

0.00

0.0

1.1

—

Legal intervention and operations of war

0.00

0.0

1.3

—

Defect, injury or illness of face

0.00

0.0

1.2

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.2

—

Nonadministration of surgical and medical care

0.00

0.0

1.2

—

Diaper [napkin] dermatitis

0.00

0.0

1.8

—

Amputation of ankle

0.00

0.0

1.4

—

Abnormal pulmonary venous return

0.00

0.0

1.5

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.1

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.3

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.0

—

Familial chondrocalcinosis

0.00

-0.00

0.0

1.4

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

3-Methoxytyramine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS